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figure 1. Hypothalamus – Pituitary – Adrenal axis, a negative feedback loop. 
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Hypothalamus – pituitary – adrenal axis
Cortisol production by the adrenals is primarily an effect of activity of the hypothalamus 
– pituitary – adrenal (HPA) axis. The median paraventricular nucleus (PVN) in the 
hypothalamus contains neurons producing corticotrophin-releasing hormone (CRH), 
which is released in to the hypophyseal portal system. CRH activates corticotroph 
cells in the anterior pituitary, together termed the corticotroph, by binding the G 
protein-coupled CRH-receptor 1.(1,2) Upon CRH stimulation, the corticotroph cells 
both secrete adrenocorticotropic hormone (ACTH) and increase its synthesis by 
cleaving pro-opiomelanocortin (POMC). The secreted ACTH subsequently binds to 
the melanocortin-2 receptor on the cell-membrane of cells in the zona fasciculata 
of the adrenal cortex.(1,3) ACTH stimulation of the zona fasciculata both maintains 
the endocrine tissue in this part of the adrenal cortex, and stimulates the secretion 
of cortisol into the bloodstream.(4) Increased serum cortisol concentrations in turn 
decrease CRH and ACTH secretion, forming a negative feedback loop (figure 1.1).(1) 
Cortisol exhibits negative feedback at the level of the pituitary, hypothalamus and 
higher brain areas affecting the HPA-axis activity. Inhibition of ACTH production by 
cortisol happens within seconds to minutes and is dose-dependent, and lasts as long 
as serum cortisol concentrations are rising. Approximately 2 to 4 hours later, ACTH 
secretion shows a delayed inhibition lasting several hours up to a day. Ultimately, an 
increase in cortisol concentrations can reduce basal ACTH production and secretion.(5) 
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figure 2. Adrenal steroid synthesis cascade.
Adapted from Arlt and Stewart, 2005.(6)
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Cholesterol is the main precursor for steroid synthesis. Cholesterol is taken up 
from the circulation in the form of low- density lipoprotein (LDL) by endocytosis. 
LDL is hydrolyzed to cholesterol, and converted to, amongst other steroids, cortisol 
through an enzymatic cascade in the mitochondria and endoplasmic reticulum, as 
shown in figure 1.2.(6) Total cortisol synthesis is on average 10-20 mg/day in adults, 
and approximately 10 mg/day in children.(6,7) Around 95% of circulating serum cortisol 
is protein-bound, primarily to cortisol-binding globulin (CBG), but also to albumin. 
Cortisol measured in serum is the cumulative of free and bound cortisol. Some factors 
are known to influence CBG concentrations, such as estrogens, liver cirrhosis, and 
hyperthyroidism, these factors also change the serum cortisol concentration. However, 
the free circulating cortisol concentration, which is the metabolically active fraction, 
remains unchanged.(6) Free cortisol is lipophilic, and readily diffuses across the plasma 
membrane. Within the cytoplasm, cortisol binds to the glucocorticoid receptor (GR). 
Upon binding its ligand, the GR dissociates from a protein complex in the cytoplasm 
and is translocated into the cell nucleus, where it exerts its effect either by directly 
binding the glucocorticoid response elements on the DNA, or through forming 
complexes with transcription factors. As a result, transcription of several hundred to 
thousand genes are either up- or down-regulated.(6,8) The GR is expressed in nearly 
every human peripheral tissue. The affinity of cortisol for the mineral corticoid receptor 
(MR) is even greater than for the GR. MR expression is limited to several tissues, in 
particular the kidneys, saliva glands and the colon. To prevent binding of cortisol to 
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the MR in these cells, cortisol is converted to inactive cortisone by 11 β-hydroxysteroid 
dehydrogenase type 2 (11βHSD2).(6) The MR does play a role in GC signaling in the 
brain and is implicated in the negative feedback loop at the level of the hypothalamus 
and anterior pituitary.(9)
The extensive mechanism regulating HPA-axis activity is subject to a variety of 
factors. Through synapses between the suprachiasmatic nucleus and the PVN, the 
HPA axis is controlled by the circadian clock. Additionally, the central clock system, 
located to the SCN, influences the ACTH sensitivity of the zona fasciculata. This 
results in the highest cortisol peak early in the morning, prior to awakening, and 
lowest concentrations in late evening and night (Figure 1.3), with additional smaller 
peaks due to daily events such as eating.(1,10) Glucocorticoids are essential for normal 
life, but even more so in adverse conditions. In 1950, Selye already recognized the 
adaptive reaction of HPA-axis activation in the case of stress, resulting in a sharp 
increase in the production and secretion of glucocorticoids, to prepare the body for 
stressful circumstances.(11) Increase of the HPA-axis activity occurs in seconds after 
the onset of a stressor, which is followed by an increase in cortisol in several minutes. 
When the stressor becomes chronic, so does the increased HPA-activity, which is 
further supported by a sensitization for glucocorticoids.(12) Both psychological and 
physiological stress, either exogenous or endogenous, all cause an increase in HPA-axis 
activity(13-15), but the increase in activity is stressor-specific, which is mainly regulated by 
neurons in the hypothalamic PVN.(15) Stress responses may however be out of balance 
with the stressor, which could in certain instances result in stress-related disease.(16)
figure 3. Twenty-four-hour plasma ACTH and cortisol curve. 
Adapted from Haus et al, 2007.(17) 
measuring Cortisol
A variety of methods for quantifying steroids have been developed, of which two 
are mainly applied in practice. One of these methods, immunoassay, is based on 
the specificity of antibodies against cortisol. Several variations of immunoassays 
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have been developed, using different antibody sources which may be enzyme, 
ligand or radiolabel- linked, or make use of competitive binding of enzyme-linked 
cortisol versus endogenous cortisol in the sample. Immunoassays provide several 
benefits, particularly the relative low costs, easy applicability and no need for highly 
specialized personnel. This makes immunoassays a popular and widely-used method. 
Nevertheless, immunoassays are also subject to several limitations, especially the 
limited sensitivity and potential cross-reactivity with other components. Another 
more recently developed method for steroid quantification is the combination of liquid 
chromatography with mass spectrometry (Liquid Chromatography tandem Mass 
Spectrometry, LC-MS/MS). With this method, steroids are separated, mainly based 
on polarity, after which the molecules are ionized and separated based on mass over 
charge ratio. LC-MS/MS allows for a superior sensitivity compared to immunoassays, 
requiring lower sample volumes, and does not suffer from cross reactivity. These 
benefits make LC-MS/MS to be the advocated method for steroid quantification.(18) On 
the other hand, the specialized equipment is costly in acquisition and maintenance, 
and requires highly trained staff. Another advantage for LC-MS/MS is that it provides 
the option of quantifying multiple components simultaneously, which may help in 
reducing the relative costs per sample/measurement. 
Cortisol is routinely measured in plasma, urine and saliva. As cortisol concentrations 
vary strongly during the day, the time point of measurement should be taken into account. 
In addition, acute stress may lead to physiologically elevated cortisol concentrations, 
which is especially relevant in plasma measurement which requires a venipuncture. 
Saliva cortisol may be falsely elevated when small amounts of blood are present in the 
saliva, because cortisol concentrations are much higher in blood compared to saliva, so 
even minute blood traces may contribute significantly. In urinalysis, urine is collected 
during a 24h period, giving information on the average cortisol concentrations during 
those 24 hours. Urine collection is however highly dependent on patient compliance, 
as urine may in some circumstances proof challenging. This also has implications 
for the reliability of the measurement. In plasma, total cortisol concentrations are 
measured, whereas in saliva and urine the cortisol concentrations reflect the free and 
unconjugated fraction, respectively. The total cortisol concentration is dependent 
on CBG concentrations, which can vary due to e.g oral anticonception, pregnancy, 
and insulin, changing the total but not the free plasma cortisol concentrations. These 
matrices are suited for assessing cortisol reactivity, but may be less fitting for long-term 
cortisol measurement. Recent studies have applied human scalp hair as a matrix for 
cortisol measurement. Scalp hair grows steadily at 1 cm per month, which provides 
the possibility to measure average cortisol concentrations of a selected period of 
weeks to multiple months, and scalp hair cortisol concentrations are not influenced 
by acute stress. In chapter 3 we describe a LC-MS/MS based method for cortisol and 
steroid hormone profiling in human scalp hair. This method was further evaluated and 
reference ranges are described, as presented in chapter 4.
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Cortisol effects
Glucocorticoids (GCs) affect myriad physiological processes in the human 
body.(6) Cortisol effects are mainly mediated through the glucocorticoid receptor, which 
is expressed in virtually all cells, and regulates transcription of up to 20% of the human 
genome.(8) The cortisol-GR complex interacts with numerous cofactors, conferring 
tissue-specific cortisol effects.(19) One of the most well-known glucocorticoid effects is 
its anti-inflammatory effect. To this, glucocorticoids have to thank their popularity as 
therapeutic drug in inflammatory and auto-immune disease.(20) In fact, cortisol has a 
wide-spread effect on the immune-system, amongst others reducing the lymphocyte 
and eosinophil counts in blood by redistribution and lymphocyte apoptosis, and 
suppression of pro-inflammatory cytokine expression.(21) Glucocorticoids also influence 
the glucose metabolism, which becomes apparent by the rise in cortisol concentration 
due to hypoglycemia. Cortisol increases blood glucose levels by stimulation hepatic 
gluconeogenesis and reducing insulin sensitivity in peripheral tissues.(22) Moreover, 
GCs are important regulators of lipid metabolism and adipose tissue, although the 
exact mechanisms and effects in physiological conditions are not yet fully understood. 
In hypercortisolemic conditions, adipogenesis occurs with a characteristic distribution 
toward increased abdominal adipose tissue, which is metabolically adverse. Triglyceride 
concentrations in blood increase and triglyceride accumulation in the liver is promoted 
by GCs.(23,24) Glucocorticoids are further implicated in stress-related behavior, influence 
other endocrine systems, have effects on the cardiovascular system, affects skin, 
muscle and bone morphology, growth, and development.(6) In children, an important 
complication of hypercortisolism in addition to the previous symptoms mentioned is 
growth retardation, causing a reduced adult height.(25) Glucocorticoids are essential for 
normal life, but may have detrimental effects in supra-physiological concentrations, as 
becomes apparent in Cushing’s syndrome, which is discussed in the following paragraph.
Hpa – axis abnormalities
Malfunctions in the HPA- axis may either lead to hyper- or hypocortisolism, which, 
taken together with the secondary effects and associated complications, have major 
health consequences and adverse effect on the quality of life, and may even be 
life-threatening.
Cushing’s syndrome and disease
Chronic hypercortisolism, resulting in Cushing’s syndrome (CS), can lead to a broad 
spectrum of symptoms. However, the clinical presentation may also be subtle and 
changing, which is easily overlooked. Indeed, the average time from disease onset 
to diagnosis is 3 to 5 years. CS is thought to be a rare disorder, with an incidence 
of approximately 2-3 per million persons per year. However, as the diagnosis is 
frequently missed and the prevalence is higher in selected patient groups with e.g. 
obesity or diabetes, CS may be more common than studies report.(26) Patients with 
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adrenal incidentaloma’s and subclinical hypercortisolism have improved glucose 
metabolism, lower blood pressure, and reduced body weight after adrenal surgery, 
which underscores the importance of also identifying subtle cases of CS.(27,28) 
Approximately 70% of endogenous CS cases are ACTH-dependent, either produced by 
a pituitary adenoma (Cushing’s disease (CD)) or by an ectopic tumor. In 30%, cortisol 
is produced autonomously in the adrenal, either by a adrenal adenoma or carcinoma, 
or by micro- or macronodular adrenal hyperplasia.(29) The clinical manifestations of CS 
are diverse, and may comprise of adipose tissue accumulation in the face, neck, and 
trunk (abdomen), weight gain, thinning skin with striae, proximal muscular weakness 
and atrophy, hypertension, glucose intolerance, fatigue, depressive symptoms, acne, 
hirsutism, hypertension, dyslipidemia, oligo-/amenorrhea, osteoporosis, and in 
children growth retardation. Treatment is focused on the underlying etiology, but even 
after biochemical remission, the long-term mortality rate remains increased.(30)
Hypocortisolism
Hypocortisolism, or adrenal insufficiency (AI), may find its origin on all levels of 
the HPA-axis. A deficiency in cortisol production due to disease within the adrenal 
cortex, termed primary AI, is most often caused by autoimmune adrenalitis (Addison’s 
disease), which may be part of an autoimmune polyglandular syndrome, responsible 
for approximately 80% of primary AI cases. A genetic mutation resulting in cortisol 
synthesis enzymes deficiency is another cause, which causes a syndrome called 
congenital adrenal hyperplasia (CAH). No treatment existed until 1949, when cortisone 
treatment became available, which turned a lethal disease into a chronic one as life-
long GC replacement therapy is needed.(31) Another 10% of primary AI cases is caused 
by tuberculosis. Symptoms are mostly nonspecific, such as weakness, fatigue, anorexia, 
and weight loss. Adrenal insufficiency may however result in a life-threatening adrenal 
crisis, with severe hyponatremia and hypovolemic shock, often induced by physiological 
stress or illness. Characteristic for primary AI is hyperpigmentation of the skin, 
specifically on skin areas exposed to pressure, e.g elbows, palmar creases and the lips. 
This is caused by stimulation of the melanocortin-1 receptor by high concentrations of 
ACTH.(32) In secondary AI, the pituitary function is affected, causing ACTH deficiency. 
Causes are multiple, e.g. prolonged use of exogenous GC’s, neoplasia, head injury, 
radiotherapy, pituitary surgery, genetic, and autoimmune, and the HPA-axis is often not 
the only endocrine axis affected. Symptoms and treatment are comparable to primary 
AI, with exception of the ACTH induced hyperpigmentation and normal aldosterone 
levels and hence sodium and water homeostasis.(33) The etiology of tertiary AI lies 
at the hypothalamus, and is most commonly induced by long-term glucocorticoid 
treatment.(32) Hydrocortisone (synthetic glucocorticoid identical to cortisol) thrice 
daily is the advised GC replacement therapy regimen in AI, with a dosing tapered to the 
individual.(31) However, it remains difficult to mimic the endogenous cortisol secretion, 
which is reflected by the increased mortality ratio, mainly due to cardiovascular and 
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infectious disease.(34,35) The long-term cortisol concentrations in children with adrenal 
hyperplasia are compared with concentrations in healthy children in chapter 7.
Congenital adrenal hyperplasia
A special case of primary AI is congenital adrenal hyperplasia (CAH). CAH is caused 
by a genetic defect in one of the enzymes of the steroid synthesis pathway, leading to 
a decreased cortisol synthesis capacity, with subsequent increase in CRH and ACTH, 
causing adrenal hyperplasia. In 95% of the cases, the genetic defect lies in the gene for 
21-hydroxylase (Figure 1.2, P450c21) and inherits as a autosomal recessive disorder.(36) 
In case of 21-hydroxylase deficiency, the androgen precursor 17α-hydroxyprogesterone 
(17OHP) is no longer converted into 11-deoxycortisol, which results in an overflow 
of androgen precursors which are secreted and converted into active androgens (e.g. 
testosterone) in peripheral tissues. This androgen excess causes prenatal virilization 
in girls, leading to ambiguous genitalia at birth, and increased growth rate with 
premature closure of the epiphyseal plates. The severity of the phenotype is mainly 
affected by the remaining enzymatic functionality; less than 20% causes classical CAH, 
with severe cortisol deficiency and androgen excess. When enzyme function is less 
than 2%, aldosterone synthesis is affected as well, resulting in salt wasting classical 
CAH, comprising approximately 75% of classical CAH patients. From approximately 
20 to 50% enzyme function, cortisol production is normal but androgen excess 
causes premature pubarche, acne, hirsutism and oligo- or amenorrhea, and is often 
not diagnosed until childhood or adolescence. This form is called non-classic CAH. 
Nowadays, CAH is part of postnatal screening, but before this was introduced classic 
CAH was often lethal in the first weeks of life.(36,37) In classical CAH, hydrocortisone 
treatment is not only focused on GC replacement, but also on reducing androgen 
excess by decreasing ACTH production. This calls for supra-physiological GC dosing, 
with adverse side-effects of its own, forcing the clinician to balance between GC 
overdosing with subsequent Cushing syndrome on one hand, and androgen excess 
with virilization, reduced fertility, or premature epiphyseal fusion on the other.(38,39) In 
chapter 8, measurement of long-term cortisol and androgen precursor hormones are 
evaluated as monitoring tool in treatment follow-up in children with CAH.
Cortisol sensitivity
Hypercortisolism without Cushingoid features may indicate a reduced cortisol 
sensitivity, as is the case in generalized glucocorticoid resistance. This is a condition 
which is usually the result of mutations in the glucocorticoid receptor gene, causing 
a defective cortisol signaling cascade. In these patients, CRH and ACTH are elevated, 
increasing cortisol production by the adrenals, because the GR is also important in 
the negative feedback of cortisol at the hypothalamus and pituitary. As the peripheral 
tissue is resistant against the higher cortisol levels, no Cushingoid symptoms develop. 
However, the increased adrenal stimulation may also increase adrenal androgen 
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synthesis, with negative effects such as acne, hirsutism, masculinization, precocious 
puberty and fertility problems. Additionally, the increased cortisol concentrations may 
induce increased mineralocorticoid receptor stimulation, causing hypokalemia and 
hypertension, in case the 11β-hydroxysteroid dehydrogenase type 2 capacity is overcome 
in kidney cells.(40-42) Glucocorticoid resistance syndromes are rare. However, the high 
variability in both therapeutic and side-effects of glucocorticoid treatment suggests that 
a more subtle variation in glucocorticoid sensitivity is rather common. This variation 
in glucocorticoid sensitivity is, at least in part, attributable to the GR gene. The GR is 
encoded by the NR3C1 gene, spanning approximately 150kb, including 9 exons. This 
gene gives rise to a number of different translational isoforms and alternative splice 
variants of the GR. Alternative splicing at the 3’-end results in use of alternative exons 
9, giving rise to GR-α and GR-β. Whereas GR-α is a ligand-dependent transcription 
factor, affecting transcription both directly and in concert with cofactors upon cortisol 
binding, GR-β does not bind ligand and is transcriptionally inactive. GR-β is thought to 
function as a dominant negative inhibitor of GR-α.(43) A single nucleotide polymorphism 
(SNP, rs6198, GR-9β, minor allele frequency 0.09) located in the 3’ untranslated region 
of GR-β increases GR-β mRNA stability, and subsequent increased expression of GR-β. 
This has been associated with a relative GC resistance, causing a pro-inflammatory 
phenotype with increased risk of amongst others rheumatoid arthritis and systemic 
lupus erythematosus, and has later been associated with increased risk of cardiovascular 
risk.(44-46) Another SNP, with a minor allele frequency of 0.013, ER22/23EK (rs6189 
and rs6190), results in a  relative increased expression of the translational isoform 
GRα-A compared to GRα-B. As GRα-B is a more active in GRE transactivation, the 
increased GRα-A levels result in a relative GC resistance, with a phenotype different 
from the GC resistance due to GR-9β. ER22/23EK has been associated with a beneficial 
metabolic profile.(47-49) Although the exact molecular mechanism has not been clarified 
yet, the SNP N363S (rs56149945) has been shown to increase the GR transactivating 
capacity and results in increased glucocorticoid sensitivity with adverse metabolic 
consequences.(46,50,51) BclI, a SNP with a minor allele frequency of 0.28, is also associated 
with glucocorticoid hypersensitivity, through an unknown molecular mechanism. BclI 
is associated with a  decreased risk for autoimmunity but, like N363S, with adverse 
metabolic parameters.(43,46) The associations of SNP’s in the GR gene with obesity and 
body fat distribution in children have been assessed in chapter 6.
Cortisol effects on a population level
In Cushing’s syndrome, with severe hypercortisolism, patients develop an adverse 
metabolic profile with obesity, hyperglycemia, dyslipidemia and hypertension. These 
symptoms together form the Metabolic syndrome. These symptoms also constitute 
(part of) the side-effects of glucocorticoid treatment. Also in subtler conditions, e.g. 
in subclinical hypercortisolism and slightly increased cortisol sensitivity, these adverse 
metabolic effects are observed.(27,28,43) 
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Obesity and the metabolic syndrome are major health concerns, affecting 1 in every 
5 adults in the western world. Risks of subsequent disease are increased, most notably 
for cardiovascular disease. Childhood obesity prevalence has tripled in the past decades. 
As a result, 17% of all US children are currently obese. Worldwide, approximately 40 
million children under the age of 5 years are obese, both in the western world and 
developing countries. Childhood obesity is an important risk factor for premature 
onset of the metabolic syndrome and cardiovascular disease in later life.(52,53)
The observation that glucocorticoids can induce obesity and subsequent metabolic 
complications, already in relatively subtle situations such as subclinical hypercortisolism 
and increased cortisol sensitivity, raises the question whether intra-individual variations 
may be implicated in the onset of obesity in the general population. This hypothesis has 
received extensive attention in studies with contradicting results, eventually leading to 
a study and review by Abraham et al.(54) in 2013, concluding that no strong associations 
between cortisol and obesity could be established. These studies based their research on 
measuring cortisol in saliva, plasma and/or urine. Although these matrices are suitable 
for cortisol measurement, they represent cortisol concentrations of only a pinpoint in 
time, with the exception of urine which is usually measured over a 24-hour span. As 
cortisol varies strongly due to circadian rhythm, acute stress and pulsatile excretion, 
these matrices may not be the most suited for establishing long-term cortisol effects. 
Recently, methods to measure long-term cortisol exposure have been developed, which 
may yield new insights into the relation between cortisol and metabolic adversities.(55,56) 
In chapters 5 and 6, the relation between long-term glucocorticoids and childhood 
obesity are assessed. 
thesis outline and aims
This thesis can be subdivided in two parts. The first part focusses on validating a novel 
method for measuring long-term cortisol concentrations in scalp hair, which has been 
developed in adults, for use in pediatric clinical practice and research. Additionally, we 
focused on improving this method by developing a LC-MS/MS based method for scalp 
hair measurement and validating this method in children as well. 
In the second part of this thesis, both the immune-assay based and LC-MS/
MS based methods are applied to challenges in clinical research and practice. The 
associations between glucocorticoids and metabolic adversities appear convincing 
in the case of Cushing’s disease, but remain to be proven in more subtle forms of 
hypercortisolism. Recent studies provide strong support for a positive association 
between long-term cortisol measured in scalp hair and cardiovascular disease and the 
metabolic syndrome in adults.(57,58) We assessed the relation between long-term cortisol 
and obesity in children. Additionally, we evaluated measurement of long-term cortisol 
concentrations and adrenal precursor hormones as a monitoring tool in the follow-
up of hydrocortisone treatment in children with adrenal insufficiency and congenital 
adrenal hyperplasia.
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In chapter 2 we aimed at validating the immunoassay based scalp hair cortisol 
measurement in children aged 4–14 years by assessing the effects of factors potentially 
influencing hair cortisol concentrations, such as age, gender, puberty, use of hair 
products, washing frequency and distance to scalp variation. Additionally, we aimed 
to establish reference ranges for use in clinical practice. In chapter 3, the aim was to 
establish a LC-MS/MS based method for long-term glucocorticoid and steroid profiling 
in scalp hair.  The aim of chapter 4 was to establish reference ranges of long-term 
glucocorticoid and steroid hormones in healthy children aged 4-18 years, and assess 
the effects of potentially confounding factors as described in the aim of chapter 2. 
Chapter 5 is a pilot study in which we aimed to assess the association of long-
term cortisol with childhood obesity. In this chapter 6, the aim was to analyze the 
associations of long-term glucocorticoid concentrations with childhood obesity and 
body fat distribution. In this study, we additionally aimed to evaluate the effects of 
SNPs in the GR gene on childhood obesity. 
To assess on how good hydrocortisone treatment in children with adrenal 
insufficiency resembles physiological cortisol synthesis in the long term, we compared 
long-term cortisol concentrations in children with adrenal insufficiency with 
concentrations measured in healthy age and gender matched controls in chapter 7. In 
chapter 8 we aimed to evaluate the measurement of long-term cortisol and androgen 
precursor hormones in scalp hair as monitoring tool in the treatment follow-up of 
children with congenital adrenal hyperplasia. 
Chapter 9 contains the general discussion of the studies performed, along with the 
implications of the results and suggestions for further research.
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abStraCt
background
Cortisol is produced in a circadian rhythm controlled by the hypothalamus-pituitary-
adrenal axis, making it cumbersome to measure long-term cortisol exposure. Hair has 
proven to be a reliable matrix for long-term cortisol measurement in adults and can 
be used as diagnostic tool for (cyclic) Cushing’s syndrome. The diagnostic applicability 
in children has not been studied, nor have the effects of development and hair care 
been evaluated in children. We aimed to establish reference ranges of hair cortisol 
concentrations (HCC) in healthy children and to evaluate the effects of age, gender, 
puberty and characteristics of hair care.
methods
In 128 healthy children aged 4-14yr, HCC were measured in a small 3cm hair-lock 
from the back of the head. 
results
HCC increased with age (p=0.04) up to age 10yr, with a mean of 5.0, 5.8, 6.8 and 8.5 pg/
mg at age 4-5, 6-7, 8-9 and 10-14 years respectively. Children age 4-7yr had significantly 
lower HCC compared to healthy adults (p=0.007). We did not find any influence on 
hair cortisol of gender, puberty or hair care characteristics. 
Conclusion
Hair cortisol concentrations can be reliably measured in childhood and reference 
ranges increase with age. HCC in children is not dependent on hair care or hair 
characteristics. 
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introduCtion
The glucocorticoid stress hormone cortisol is the end product of the hypothalamus-
pituitary-adrenal (HPA) axis. Both a deficiency and an excess of cortisol have 
detrimental effects, resulting in both physical and psychiatric symptoms as manifested 
in Cushing’s syndrome and Addison’s disease. Cortisol is measurable in several 
matrices, each with its own merits and drawbacks. Cortisol measurements in serum 
and saliva provide a  snap-shot indication of cortisol concentrations but are subject 
to the circadian rhythm, pulsatile excretion and acute stress, thereby impeding 
interpretation (1). Urinary free cortisol is less subject to these drawbacks and provides 
a cortisol concentration spanning 24 hours. However, 24h urine collection is often 
cumbersome and unreliable. Moreover, most of the deleterious effects of hyper- and 
hypocortisolism are mediated by long-term exposure. A more suitable matrix for 
long-term cortisol measurement is scalp hair. Hair is readily accessible, sampling is 
non-invasive, samples can easily be stored at room temperature and cortisol can be 
measured using an relatively simple method. Measurement of hair cortisol has been 
shown to be a valuable diagnostic tool in situations of extreme hypercortisolism such 
as seen in Cushing’s syndrome (2), but also hair cortisol concentrations (HCC) within 
the physiological range have been associated with the metabolic syndrome (3), obesity (4) 
and cardiovascular disease (5). Recently, HCC are being explored as a stress biomarker 
in children (6-8).
Hair cortisol measurements have been validated in adults (2,9) and so far most studies 
measuring hair cortisol were in adults. A prerequisite to study hair cortisol in children 
is the availability of reference values, according to age, gender and pubertal stages. 
These have hitherto not been published. 
In this study we aimed at measuring HCC in healthy children aged 4-14 years to 
establish reference ranges. Furthermore, we evaluated factors potentially influencing 
HCC such as age, gender, puberty, use of hair products, washing frequency and distance 
to scalp variation. 
metHodS
Healthy children were enrolled during visitation of primary schools and from the 
siblings of children attending the pediatric outpatient clinic. Children were excluded 
if they were using glucocorticoids, both systemic and topical, or medication known 
to alter glucocorticoid metabolism. In total, HCC were measured in 128 children 
aged 4 through 14yr. Only two children were non-Caucasoid by appearance. Parents 
were requested to fill out a questionnaire about general health, the use of medication 
and the hair care characteristics of their child. Hair care characteristics, which were 
queried are hair washing frequency (< 1x/week, 1-2x/week, 3-4x/week, >4x/week), 
the use of hair products on the day of sampling (yes/no and type: none, mousse, gel, 
wax, spray, other), frequent sweating at the scalp (yes/no) and hair treatment in the 
Chapter 2
28
last six months (bleaching, dyeing, perming). Hair color was noted during preparation 
for analysis. In all children hair samples were obtained and anthropometrics were 
measured by one trained staff-member as follows: Standing height was measured in 
centimeters with the precision of 1 millimeter with a wall mounted stadiometer. Body 
weight was measured in kilograms with the precision of 100 gr with electric scales. 
Waist circumference (WC) and hip circumference (HC) were assessed in centimeters 
with the precision of 1 mm, taken on bare skin with both feet standing on the floor. 
The WC was measured mid-way between the lowest rib and the upper side of the 
pelvis. The HC was measured at the height of the widest range of the buttocks and 
the upper side of the os pubis. WC and HC measurements were taken twice and the 
mean was used as outcome. In children aged 7 and above Tanner puberty staging was 
assessed by a trained research nurse. Puberty was defined as Tanner stage M>1 in 
girls and testis volume ≥ 4cc in boys. Approval was given by the local Medical Ethics 
Committee, written informed consent was obtained from parents and informed assent 
from participants.
Hair collection
Of each participant, a lock of hair were cut from the posterior vertex as close to the 
scalp as possible using small surgical scissors. This area has been shown to have the 
lowest inter-lock variation (10). Hair locks were taped to a paper form with scalp end 
marking and stored at room temperature until analysis. 
Hair analysis
Hair samples were prepared and analyzed as described previously (9). Briefly, the 
proximal three cm hair segment was weighed (samples approximately between 25 
and 40mg) and minced using small surgical scissors. The hair was extracted in 1mL 
methanol for 16h at 52°C with gentle shaking. The extract was transferred to a glass 
tube and the methanol was evaporated at 37°C under a constant stream of nitrogen 
and reconstituted in 250µL phosphate buffered saline (PBS) pH8.0. After vortexing, 
the samples were analyzed using a commercially available cortisol ELISA kit (DRG 
Instruments, GmbH, Marburg, Germany) following the manufacturer’s directions. 
Cross reactivity as reported by the manufacturer are as follows: Corticosterone 29.0%, 
Cortisone 3.0%, 11-Deoxycortiol <1.0%, 17-OH Progesterone <0.5%, Testosterone 
<0.10% and Estradiol <0.10%.
assay variation
The intra-assay and inter-assay variation were analyzed on internal quality controls 
used for routine saliva cortisol measurement, measured in duplicate on five 
consecutive assays. The intra-assay coefficients of variance (CV) were 3.1% at 4.4ng/
mL, 2.3% at 21.3 and 2.6% at 35.0 ng/mL. The inter-assay CV’s were 7.0%, 2.3% and 
8.2% respectively. 
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Variation within lock between proximal and distal segments (distance 
to scalp variation)
To asses intra-individual variation over time, we measured HCC in 15 participants in 
the distal 3cm segment adjacent to the proximal 3cm (from 3cm to 6cm distal from the 
scalp) of hair within a single hair lock. These participants were randomly selected with 
the requirement that hair length was at least 6cm. The Spearman correlation between 
the two measurements is reported. 
Statistical analysis
Statistical analyses were performed using SPSS 20.0 (IBM Corp., Armonk NY, USA). 
HCC were log10-transformed to achieve normality. Anthropometrics standard 
deviation (SD) scores were calculated based on the 1997 Dutch nationwide growth study 
(11) using Growth Analyser RCT (Growth Analyser B.V., Rotterdam, the Netherlands). 
Waist circumference to height ratio was calculated by dividing waist circumference 
(cm) by height (cm). Relations between hair cortisol and age and anthropometrics 
were analyzed by linear regression. Age-specific reference ranges are based on linear 
regression 95% prediction intervals. Differences in HCC between age groups were 
tested using Students t-test. Proximal and distal hair samples were compared using 
Spearman’s  correlation and differences were analyzed using Wilcoxon signed ranks 
test. Effects of hair care and hair characteristics on cortisol concentrations were 
assessed using one-way Analysis of Variance (ANOVA). 
reSuLtS
General characteristics of participants are shown in Table 1. Hair cortisol  concentrations 
increased significantly with age (log-transformed β=0.031, R=0.18, p=0.04, Figure 1), 
which is emphasized by the significantly lower HCC in children aged 4-7 years 
compared to 141 healthy adults as previously measured (9) (Mean and 95% CI: 4.6 [3.3, 
6.1] vs. 7.5 [6.1, 9.1] pg/mg,  p=0.008) and compared to children aged 8-14yr (Mean 
and 95% CI: 4.6 [3.3, 6.2] vs. 9.0 [6.9, 11.6] pg/mg, p=0.001). Cortisol concentrations 
were not different between children aged 8-14 and adults (p=0.14). Neither puberty 
nor gender influenced HCC (p= 0.88 and p=0.78 respectively). Waist circumference 
table 1. General characteristics and reference ranges per age category
Variable N=128
Age, mean and [range], yr. 8.4, [4.25-14.13]
Female, N and % 65, 50.8%
BMI SD score, mean and SD -0.25, 0.99
Waist circumference SD score, mean and SD 0.72, 0.83
Puberty, N and % 26, 20.3%
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showed a significant association with HCC (log-transformed β=0.13, r=0.19, p=0.04, 
adjusted for age. Figure 2), the association between waist to height ratio did not reach 
statistical significance (log-transformed β=0.16, r=0.19, p=0.07, adjusted for age). Hair 
cortisol was not correlated with BMI (p=0.50, adjusted for age).
age-specific reference ranges
Age-specific hair cortisol reference ranges based on linear regression 95% prediction 
intervals are listed in Table 2. HCC in children above age 10 were not significantly 
different from adults and were hence pooled in one category.
Hair care 
Hair care characteristics in terms of washing frequency, hair product use or type 
of hair product did not influence hair cortisol content (p=0.33, p=0.73 and p=0.22, 
respectively), nor was hair cortisol content affected by hair color or frequent sweating 
at the scalp (p=0.72 and p=0.25, respectively). Adjustment for age did not change 
these results. None of the children participating in the current study dyed, bleached or 
permed their hair. 
distance to scalp variation
Intra-individual differences in hair cortisol measurements between the proximal 3cm 
hair segment and a distal 3cm hair segment (3-6 cm distal from scalp) measured in 
15 children (male N=8) showed a significant correlation (Spearman r=0.76 p=0.001). 
No significant difference in HCC between proximal and distal segments was observed 
(p=0.43). 
figure 1. Hair cortisol distribution over age. Each dot represents a single individual. Lines show linear 
regression and limits of 95% prediction interval. 
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diSCuSSion
Hair cortisol concentrations in healthy children were readily measurable, and increased 
significantly with age. In other matrices, e.g. serum or saliva, the relation between age and 
cortisol concentrations has yielded conflicting results. Knutsson et al. found no effects of 
age on serum cortisol in a study in 235 healthy children (12). However, two larger studies 
on serum cortisol in 762 and 1482 healthy children aged 0-18, respectively,  reported 
high cortisol variance in neonates and infants, after which cortisol rapidly decreased 
to subsequently increase steadily with age up to adulthood (13,14). More specifically, the 
median serum cortisol concentration in the study by Elmlinger et al. was 218 nmol/L in 
girls and 253 nmol/L in boys aged 4-6 years and rose steadily up to 466 nmol/L (girls) 
and 440nmol/L (boys) in 14 year olds. These study results support our findings in hair 
cortisol. Very few studies report hair cortisol measurement in children. Dettenborn et 
al. reported a decrease in hair cortisol over age in 28 children 1 to 9 years of age (15). 
This seems contradictory to our findings, however the numbers per age category in that 
table 2. Hair cortisol concentration reference ranges per age category
Variable Hair cortisol concentration (pg/mg)
Age 4-5, n=27 5.0 [0 – 43.4]
Age 6-7, n=34 5.8 [0 – 49.1]
Age 8-9, n=27 6.7 [0.1 – 56.0]
Age 10-14, n=40 8.5 [0.3 – 69.5]
Reference ranges are described by linear regression mean and 95% prediction interval limits per age category
figure 2. Waist circumference plotted against hair cortisol concentration. Line shows unadjusted 
correlation. Linear regression adjusted for age: log transformed β=0.13, p=0.04.
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study are low and the sample mainly composed of children under 4 years of age (mean 
age 3.6 years) including only 8 children aged above 5, whereas we studied children 
4-14 years old (mean age 8.4 years). The differences may be explained in the relative 
overrepresentation of very young children, as serum cortisol show high and variable 
concentrations during infancy(13). The high variability in HCC at young age has also 
been demonstrated by Karlén et al, measuring hair cortisol in children of 1, 3, 5 and 
8 years of age (16). HCC showed a large variation in the very young, which decreased 
with increasing age. However, no clear difference was visible between the age of 5 and 8 
years. HCC may be further elevated during the first years of life when hair morphology 
and growth is subject to major changes (17). After the age of 2, hair has been observed to 
increase in cross-sectional surface area and in the percentage of medullated hair with age 
up to puberty (18). The influence of these morphological changes on hair cortisol content 
is unknown. Theoretically, linear hair growth rate may also influence HCC. Research on 
hair growth rate in healthy children is scarce. Growth rates of 0,3-0,4 mm per day have 
been reported (17). One study suggests a slightly higher hair growth rate in childhood in 
boys age 3-9yr. (17,19). It seems unlikely that the hair growth rate contributes significantly 
to hair cortisol content, as hair grows slowly, there is ample time for circulating cortisol 
to achieve an equilibrium at the hair follicle and to completely diffuse into the forming 
hair shaft, even in the case of a slight increase in growth rate. However, differences in 
growth rate may have consequences if consecutive segments of hair are used to construct 
a timeline of cortisol exposure. For such applications, it would be useful to have more 
data about the hair growth rate in children. 
To validate hair cortisol measurement in children, factors that could influence 
cortisol concentrations were studied. HCC were not affected by hair color, hair washing 
frequency or use of hair products. The effect of topical use of glucocorticoid treatment, 
e.g. hydrocortisone cream, was not assessed, as this was a criterion for exclusion. Despite 
recent evidence showed extensive sweating at the scalp may increase HCC (20), no effect 
of frequent sweating at the scalp as reported through a questionnaire was found in the 
present study. However, noting extensive sweating at time of sampling as suggested by the 
authors was not performed. Hair segments up to six cm from the scalp were measured 
in the current study. No significant difference in HCC were found between the proximal 
(cm 0 - 3) and distal (cm 4 – 6) hair segments, and distal and proximal hair segments 
showed a high correlation, supporting the previous evidence of stable incorporation of 
cortisol in hair. With the current method HCC can be reliably measured at least up to six 
cm. As none of the children participating in the current study had undergone any hair 
treatment, e.g. dyeing, straightening or perming, the effects of these treatments could 
not be assessed. The same applies to ethnicity, as almost all participants were Caucasian. 
These findings are in line with the previously described findings in adults (5).
Stressing the value of hair cortisol as a reflection of long-term systemic cortisol 
exposure, hair cortisol was significantly correlated with waist circumference in 
children, since visceral fat redistribution is one of the hallmarks of cortisol tissue 
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effects. Also in adults positive correlations between waist and hair cortisol levels have 
been demonstrated (3,9). In addition, recently strong evidence was presented that HCC 
in adults are related to metabolic syndrome and cardiovascular disease (3,5).
Several limitations of the current study need to be mentioned. First, the population 
is primarily Caucasian, limiting the applicability of the reference ranges to other 
ethnicities. However, hair color has been observed not to influence HCC (15), so there 
are no clear indications that HCC is different in other ethnicities. Additionally, the 
current reference ranges do not cover all pediatric age categories. The findings described 
here and in other studies (13) underline the need for reference ranges measured in all 
ages, rather than extrapolating results to other ages. Hair cortisol measurement in 
children under the age of 4 years deserve extra attention, as hair characteristics in 
this age group change dramatically (17-19). Although Figure 1 suggests HCC increases 
up to approximately the age of 10, no distinct cut-off age at which the increase in 
HCC levelled off could be determined in the current study using a linear regression 
model. HCC measurement using different methods for extraction or different ELISA 
kits render different results (10,15), and while immunoassays will remain in use for HCC 
measurement, especially in settings where equipment and money are scarce, methods 
with a higher sensitivity such as gas- and liquid chromatography mass spectrometry, 
will eventually be widely employed. The comparison of results between varying 
methods is an important focus for future research (21). 
A strength of this study is the sample size, exceeding 20 children per 2-year age 
group with even distribution in gender. The additional validation of these data and 
this technique is supported by the information on pubertal staging and on potential 
confounders. With these reference data we have a foundation for further research on 
the value of using HCC in pediatric clinical practices.
ConCLuSion
Hair cortisol concentrations in childhood can be reliably measured. HCC reference 
ranges increase with age between 4 and 9 years of age until concentrations comparable 
to adults are reached in puberty. This study emphasizes the need for age-specific 
reference ranges. Hair cortisol measurement has the potential of becoming a valuable 
tool in diagnosing hypothalamus-pituitary-adrenal diseases in children in the future. 
Further research is needed to clarify its value in pediatric clinical practice and research. 
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abStraCt
background
Liquid chromatography – tandem mass spectrometry (LC-MS/MS) is the method 
of choice for quantification of steroids. Human scalp hair provides the possibility to 
measure long term retrospective steroid concentrations, which is especially useful 
for steroids with large time-dependent fluctuations in concentration, such as the 
glucocorticoid cortisol. 
aim
We set-up and validated a LC-MS/MS based method for long-term steroid profiling, 
quantifying cortisol, cortisone, testosterone, androstenedione, dehydroepiandrosterone 
sulfate (DHEAS), and 17-α-hydroxyprogesterone (17OHP).
method
Hair locks were cut from the posterior vertex of healthy male and female volunteers and 
washed in isopropanol. Steroids were extracted using methanol, extract was cleaned up 
by solid phase extraction and measured on a Waters XEVO-TQ-S LC-MS/MS. Lower 
limit of quantification, precision, matrix interference and intra-individual variation 
were determined.
results
The functional sensitivity of our steroid analysis was < 1.3, < 9.3, 2.3, <1.3, <15.9, 1.87 pg/
mg hair for cortisol, cortisone, testosterone, androstenedione, dehydroepiandrosterone 
sulfate (DHEAS), and 17OHP respectively. Measured over a nine-month period the 
inter-run CV were below 16% for all steroids. Intra-individual coefficients of variation 
were below 15% for all steroids, except 17OHP (19.7%). 
Conclusion
The authors present a LC-MS/MS based method for long-term steroid profiling in 
human scalp hair, potentially providing novel insights by a multitude of clinical and 
research applications in the field of endocrinology.
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introduCtion
Steroid measurement in human scalp hair was originally set-up for use in determination 
of exogenously administrated steroids, e.g. performance enhancing drugs in sports 
and forensic medicine(1,2). In the past decade, measurement of endogenously produced 
steroids, especially the glucocorticoid hormone cortisol, has drawn increasing 
attention. As human scalp hair at the posterior vertex grows 1 cm per month, cortisol 
in a 1 cm hair segment reflects the mean systemic cortisol exposure of one month. 
Thus, hair provides a long-term cortisol measurement, offering the ability to measure 
months to years in retrospect, and is thought to reflect the free cortisol fraction. Hair 
cortisol has shown to be a valuable biomarker in research on both mental (3,4) and 
physical health(5,6). It has been posted as a risk factor for the metabolic syndrome(7) 
and cardiovascular disease(8). Moreover, measurement of long-term cortisol exposure 
using hair has been shown to be clinically relevant in e.g. diagnosing (cyclic) Cushing’s 
syndrome(9) and monitoring of hydrocortisone treatment(10,11). 
Most studies reporting on cortisol concentrations in scalp hair are based on 
immunoassays, either in-house developed or commercially available saliva-cortisol 
assays (6,12-14). Immunoassays are technically straightforward, explaining their popularity, 
despite drawbacks such as cross reactivity and the limitation to single component 
measurement per assay. Superior methods based on mass spectrometry have been 
available for decades, but were costly and unsuited for high-throughput routine laboratory 
measurements. In recent years, mass spectrometry has overcome these drawbacks and, 
with its superior specificity and sensitivity and its multi-analyte capabilities, has become 
the preferred method for steroid analysis in high-quality clinical research(15). 
Taking advantage of the multi-analyte analysis, we established a LC-MS/MS assay 
for profiling glucocorticoids and sex steroids in human scalp hair. Here, we describe 
the method and present the validation of this novel technique providing long-term 
steroid profiles through a non-invasive procedure. To date, only one report on the use 
of an LC-MS/MS based method for scalp hair steroid profiling has been published. 
(16) The current method adds to this by providing results on 17α-hydroxyprogesterone 
(17OHP) and dehydroepiandrosterone sulfate (DHEAS) thereby expanding potential 
applicability of scalp hair analyses for example in therapy monitoring of patients with 
congenital adrenal hyperplasia.
materiaLS and metHodS
Chemicals
Steroids were purchased from Sigma-aldrich (Zwijndrecht, the Netherlands). Deuterated 
cortison-d8 was purchased from Buchem B.V. (Apeldoorn, The Netherlands). 
Androstendione-d5, cortisol-d3, 17α-hydroxyprogesterone-d8, testosterone-d5,  and 
dehydroepiandrosterone sulfate-d6 were purchased in a dried mixture from Perkin 
Elmer (Turku, Finland). LC-MS grade isopropanol and LC-MS grade methanol 
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(MeOH) were purchased from Biosolve B.V. (Valkenswaard, The Netherlands). Stock 
solutions of cortison-d8 in methanol was prepared by weighing, as were stock solutions 
of each unlabeled steroid. Working solutions were prepared by diluting stock solutions 
in MeOH to a concentration between 1 and 1000 nmol/L. Of each working standard 
(S1-S10), 100 µl was mixed with 100 µl of diluted internal standard working solution 
and dried under a gentle stream of N2 at 50°C. The dry residue was reconstituted in 
100 µl of initial mobile phase. Two standard curves of ten calibration standards were 
prepared on each day of analysis.
Controls
Two internal human control materials were established by pooling extract from 
a large supply of scalp hair, which was evaporated to dryness under a flow of N2, and 
reconstituted in methanol at a concentration of 200 mg/mL. This pool was divided 
in 100 µL aliquots and stored at -20oC in glass vials. On each day of analysis the two 
internal controls were measured twice. 
Specimens
Hair sampling
Hair locks were obtained from healthy adult male and female volunteers, not using any 
medication. Approximately 100-200 hairs were cut from the posterior vertex, close to 
the scalp, using small surgical scissors, marking the scalp-end. The proximal 3 cm of 
hair, reflecting the most recent three months, were cut in 1 cm segments, weighed and 
transferred to disposable glass tubes. 
Sample preparation 
Hair samples were washed by gently shaking in 2 mL LC-MS grade isopropanol at room 
temperature. They were allowed to dry for a minimum of 2 days. Ten to 30 mg of whole, 
nonpulverised hair was weighed out and transferred into a glass tube, capped with 
glass marbles. Subsequently, 1.4 mL MeOH and 100 µl internal standards were added 
and the hair was incubated for 18 h at 25°C for extraction. Samples were centrifuged 
at 4302x g (4500 rpm ), 4oC for 5 minutes and 1 ml of the clear supernatant was 
transferred into a new glass tube. The MeOH was evaporated at 50oC under a constant 
stream of N2 until the samples were completely dried. The dry residu was resuspended 
using 1 ml 2% MeOH and vortexed for 1 min. Hair extracts were subsequently cleaned 
by solid phase extraction using Oasis HLB 30μm 96-wells extraction plates on a 96-
wells positive pressure manifold (Waters Corporation, Milford, MA, USA). Wells were 
conditioned with 1 mL of MeOH followed by 1 mL Milli-Q. Subsequently, samples 
were loaded with the resuspended extract (1 mL), washed with 1 mL 30% LC-grade 
MeOH in Milli-Q, and eluted twice with 300 uL MeOH. Samples were evaporated to 
dryness at 50oC under a constant flow of N2 and stored at 4oC until analysis. Before 
injection, the dry residu was resuspended in the initial mobile phase.
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LC-mS/mS analysis
Conditions and procedures 
All steroid hormones were measured simultaneously with a LC-MS/MS method. 
The  chromatographic separation was performed on a Waters® Acquity™ UPLC 
HSS T3 1.8 µm column and in-line filter frit 0.2 µm with a  H2O /MeOH gradient 
(Waters Corporation, Milford, MA, USA). The Waters XEVO-TQ-S system (Waters 
Corporation, Milford, MA, USA) was equipped with an ESI source operating in 
the  electrospray positive mode except for DHEAS (negative ESI). The HPLC flow 
rate was set to 250 µl/min with mobile phase consisting of solution A, H2O with 1.25 
mM ammonium acetate, and solution B, LC-grade MeOH with 1.25 mM ammonium 
acetate, using the following gradient elution: Initial – 1.5 min 70% A, 30% B; 8 min 35% 
A, 65% B; 8.1 min 100% B; 8.1-9.5 min 100% B; 9.55 70% A, 30% B; 9.55-10 70% A, 
30% B. A volume of 40 µl sample solution was injected.  The ion transitions are given 
in Table 1. Peak integration and calculations of concentrations against the standard 
curve were performed using Waters Masslynx vs. 4.1 (Waters Corporation, Milford, 
MA, USA). Steroid peak integrations were reviewed and manually integrated by two 
independent persons when automated peak integration feature incorrectly of partially 
integrated peaks.
table 1. Mass spectrometer parameter settings and steroid ion-transitions
Steroid Internal standard Precursor ion 1st – 2nd transition Time ESI Collision V
Cortisol Cortisol-d3 363.168 121.108 - 97.100 3.84 + 24 – 24
Cortisone Cortisone-d8 361.200 163.100 - 105.100 3.60 + 24 – 36
Testosterone Testosterone-d5 289.232 97.097 - 109.074 6.19 + 20 – 24
17α-OHP 17α –OHP-d8 331.168 97.097 - 109.073 6.58 + 22 – 26
Androstenedione Adion-d5 287.168 97.097 - 109.970 5.93 + 20 – 22
DHEAS DHEAS-d6 367.104 80.007 – 96.99* 3.43 - 66 – 32
ESI, Electrospray Injection charge; V, Voltage; CV, Coefficient of variation in %; OHP, Hydroxyprogesterone; 
Lower limit of quantification
The functional sensitivity (lower limit of quantification, LLoQ) is the lowest analyte 
concentration that can be reproducibly measured with an intermediate precision CV 
of ≤ 20 %. The LLoQ was determined in hair extracts of male and female adults, by 
serial dilution of hair extract, starting with 40 mg/mL to 0.3125 mg/mL. The LLoQ was 
calculated in pg/mg hair.
Precision 
Precision was determined using human scalp hair extraction pools as internal controls. 
We measured six steroids in duplicate over a period of 9 months. 
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Intra-individual variation
Intra-individual variation due to repeated sampling and measurements was determined 
by analyzing 5 separate hair samples per individual in parallel, obtained from 5 volunteers 
(4 male, 1 female). All samples were obtained from the posterior vertex at the same moment. 
To assess the variety of steroid concentrations along the consecutive hair segments, 
we constructed time-lines of hair samples of three consecutive segments of 1 cm 
followed by two segments of 3 cm, totaling to 9 cm, in 6 volunteers (3 male, 3 female). 
Hence, subjects for this analysis were selected on a hair length of at least 9 cm. 
Matrix interference
To evaluate the effect of hair matrix on LC-MS/MS response we added different 
concentration of non-deuterated steroids to different weights of hair (2.5-5-10-20 mg). 
Concentration ranges of non-deuterated cortisol, cortisone, 17OHP, androstenedione, 
DHEAS and testosterone added to the hair extracts were 31-509 pg, 24-396 pg, 
3.6-62 pg, 23-388 pg, 524-8456 pg and 8.4-136 pg. The mean recoveries were calculated 
as follows: (spiked sample – blanc sample) / measured spiking concentration * 100%.
reSuLtS
precision
Over a nine-month period, coefficients of variation for cortisol, cortisone, 17OHP, 
androstenedione, DHEAS and testosterone in internal hair pools were 14.8, 15.3, 15.0, 
14.9, 13.5, 16.0 %, respectively. 
Extracting 10 mg hair from 2 individuals gave an intra-day CV for cortisol, cortisone, 
17OHP, androstenedione, DHEAS and testosterone of 1.9% (range 0.9-2.9%), 4.7% 
(range 4.5-4.8%) , 7.7% (range 6.2-9.1%), 2.5% (range 2.0-3.0%), 6.3% (range 5.7-6.9%) 
and 3.1% (range 2.3-3.9%), respectively. 
Using human hair pools the LLoQ of Cortisol, Cortisone, 17-OHP, Androstenedione, 
DHEAS and Testosterone was < 1.3, < 9.3, 1.87, <1.3, <15.9 and 2.3 pg/mg hair 
respectively for a 10mg hair sample.
intra-individual variation
In five volunteers, five hair samples per individual were obtained which were separately 
extracted and measured, to determine the total variation of repeated sampling and 
measurement. The mean CV was 14.0% for cortisol, 14.8% for cortisone, 19.7% for 
17-OHP, 8.5% for androstenedione, 10.0% for DHEAS, and 14.8% for testosterone. 
The intra-individual variation was higher compared to the intra-day variation of the 
described method.
matrix interferences
No distinct trend in the effect of different hair sample weights used for extraction 
procedure (range 2.5-20 mg) on the recovery of the six studied steroids was observed. 
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We found a mean recovery of the non-deuterated steroid added to the hair extract of 
110% for cortisol, 111% for cortisone, 126% for androstenedione,  113% for testosterone, 
102% for 17OHP and 108% for DHEAS. With the present LC-MS/MS procedure we are 
able to measure steroids in hair sample extracts derived from 2.5 up to 20 mg.
wash-out
Figure 1 shows mean steroid concentrations in 6 individuals (3 male) along successive 
hair segments. Steroid concentrations decrease gradually from proximal to more distal 
hair segments. Only cortisone showed a significant decrease in the most proximal 3 cm 
hair (p=0.01). 
diSCuSSion 
We present a LC-MS/MS based method for long-term steroid profiling in human scalp 
hair, potentially providing novel insights in a variety of clinical challenges in the field 
of endocrinology. Using this method, we were able to quantitatively measure cortisol, 
cortisone, 17OHP, androstenedione, testosterone and DHEAS in human scalp hair 
samples in concentrations well above the limit of quantification. This method resembles 
the method described by Gao et al.(16), but lacks the need for an online SPE system 
and adds the quantification of the clinically relevant adrenal steroids DHEAS and 
17OHP. Due to the high sensitivity provided by state-of-the-art mass spectrometers, 
only small hair samples of volumes are needed. With the current method, we prefer 10 
mg as the optimal amount of hair, although lower weights up to 2.5 mg also gave good 
results. Limiting the maximum amount of hair is advised, as extraction of larger hair 
samples may introduce matrix interference, limiting the reliability of the measurement. 
The minimum amount of 2,5 mg hair is the lowest amount  that has been reported 
until now. In previous studies measuring glucocorticoids in scalp hair by LC-MS/MS 
reported using much higher weights, ranging from 50(17) to 150 mg(18), whereas Gao et 
al.(16) used 10mg hair locks. The low amount needed for this assay is of added value, 
as the need for high volumes of hair is an important barrier for the use of hair steroid 
profiling in patient care or in large epidemiological studies.
In a study on hair cortisol using fluorescence detection (HPLC-FLU), Gao et al.(19) 
showed a decrease in hair cortisol contents in distal segments along the hair shaft. This 
was previously reported by Kirschbaum et al.(20) using an immunoassay. In our enzyme 
linked immunoassay (ELISA) method, we did not observe this decrease.(14) However, 
using the current LC-MS/MS method, we  observed a gradual decrease in steroids 
along the length of the hair shaft, most pronounced in the more distal segments. Distal 
hair samples may have suffered more insults such as UV-damage and repeated water 
and soap exposure, making these parts more susceptible to leak contents during e.g. 
a washing step. In the previously described immunoassay method, hair was not washed 
prior to analysis. (14) The current method does include a washing step using iso-propanol, 
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we speculate this might contribute to the observed decrease of steroid content along 
the hair shaft. This finding should be taken into account in the assessment of time-lines 
over longer periods. 
To date, a variety of methods on measurements of steroids in hair, mostly cortisol, 
have been published. Most methods are based on immunoassays while LC-MS/MS 
methods on endogenous hair steroids are rising. These methods vary in the extraction 
protocol and the assay used. Efforts for international validation and external quality 
assurance schemes are ongoing and the first results show high correlation between 
the varying methods(21). In our studies on validating hair cortisol measurement using 
an ELISA in both adults(14) and children(22), no contributions of hair treatment (e.g. 
washing frequency, hair product use, hair dyeing etc.) to steroid concentrations 
have been found. This remains to be confirmed for the LC-MS/MS based method. 
Additionally, reference ranges and the effects of age and gender need to be established. 
In conclusion, we describe a sensitive and robust LC-MS/MS method for the 
quantification of long-term adrenal and sex steroid concentrations retrospectively in 
human scalp hair. Measurement of cortisol in hair is a promising tool in the diagnosis of 
(cyclic) Cushing’s syndrome(9), for treatment monitoring in  e.g. adrenal insufficiency(11), 
as a risk factor for cardiometabolic diseases(7,8), and is valuable for numerous other 
applications(5,23). The high sensitivity of the LC-MS/MS based measurement and the 
addition of other adrenal and sex steroids broadens the scope of clinical use of hair 
analysis to a variety of endocrine diseases e.g. Addison’s disease, congenital adrenal 
hyperplasia, female hyperandrogenism and male hypogonadism. 
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abStraCt
background
Human scalp hair is a novel matrix for determining long-term steroid concentrations, 
with wide-spread applicability. Recently we published a Liquid Chromatography 
tandem Mass Spectrometry (LC-MS/MS) based method for long-term steroid hormone 
profiling in human scalp hair. The aim of this study is to establish age-adjusted reference 
ranges and evaluate the effects of potential confounders and environmental factors 
such as hair washing frequency, hair product use, and hair color. This knowledge is 
vital for application of this method in research and clinical practice.
methods
Healthy children age 4-18 years were enrolled through elementary and secondary 
school visits. The proximal 3 cm hair was analyzed by LC-MS/MS, measuring cortisol, 
cortisone, androstenedione, 17α-hydroxyprogesterone (17OHP), testosterone and 
dehydroepiandrosterone sulfate (DHEAS). Height and weight were measured. 
Questionnaires on hair care characteristics were filled out by a subset of children.
results
Age-adjusted reference ranges were established. Cortisol and cortisone show a slight 
increase over age. androstenedione, 17OHP, and testosterone show a marked increase 
over age, leveling off around the age of 14yr. The median testosterone concentrations are 
significantly higher in boys from the age above 12yr, compared to girls. Hair washing 
frequency and use of hair products did not affect hair steroid concentrations, whereas 
ethnicity and hair color were associated with a difference in hair steroid hormone 
concentrations.
Conclusion
This study provides age-adjusted reference ranges for clinical use. The non-invasive 
measurement of a complete long-term steroid hormone profile broadens the potential 
applications in both clinical practice and in research. 
Scalp hair Steroid hormone reference rangeS
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introduCtion
Measurement of endogenously produced hormones is a cornerstone in the endocrine 
clinic. Routinely used matrices for hormone quantification are serum, urine, as well 
as saliva. A relatively novel matrix which is rapidly rising in popularity is human 
scalp hair.(1)  Hair has several unique characteristics, such as providing a long-term 
retrospective reflection of cumulative hormone concentrations and non-invasive 
sampling. These features make the use of scalp hair attractive for both research and 
clinical practice. Studies measuring glucocorticoids in hair have linked increased long-
term cortisol and cortisone to obesity(2-4), the metabolic syndrome (5) and cardiovascular 
disease.(6,7) Additionally, measurement of cortisol in hair may be of use in the diagnosis 
of Cushing’s disease(8,9), as well as  in evaluating cortisol levels and prevention of 
hydrocortisone overtreatment in adrenal insufficiency.(10-13) Recent studies have shown 
that a broad spectrum of steroids are measurable in hair matrix(14-16), widening the 
potential application of scalp hair as a matrix in endocrinology. 
The spectrum of endogenous steroids in scalp hair measurable by LC-MS/MS 
thus far, consists of cortisol, cortisone, androstenedione, 17α-hydroxyprogesterone 
(17OHP), dehydroepiandrosterone, dehydroepiandrosterone sulfate (DHEAS), 
testosterone, epitestosterone, corticosterone and progesterone.(14-16) It has been shown 
that the distance of the hair segment from the scalp influences steroid concentrations, as 
concentrations decrease along the hair shaft.(15,16) Inter-lock variance as reported using 
LC-MS/MS  is approximately 15%(16), which is comparable to previous immunoassay 
based studies.(17) The setup and validation of an LC-MS/MS based method requires 
costly investments in time and equipment, as well as the need for specialized personnel. 
Although the described methods have been validated extensively, basic prerequisite 
knowledge about effects of environmental factors linked to the hair matrix when using 
an LC-MS/MS based method, e.g. hair color, hair treatment, but also effects of age and 
gender, is lacking. Prior to application of hair analysis in research or clinical practice, 
the effects of these factors need to be evaluated and reference ranges in a healthy 
population should be established. 
The aim of this study is to establish steroid profiles in healthy children aged 4-18 
years, assessing the effects of hair matrix linked factors such as color, treatment and 
hair product use, and provide age adjusted reference ranges for cortisol, cortisone, 
testosterone, 17OHP, dehydroepiandrosterone sulfate (DHEAS), and androstenedione. 
metHodS
Healthy participants were enrolled as described previously (18), through visitation of primary 
and secondary schools, and siblings of children attending the pediatric outpatient clinic. 
Criteria of exclusion were chronic disease, the systemic use of glucocorticoids (GC) or 
other medications affecting steroid metabolism. This study was approved by the medical 
ethics committee, written consent was obtained from parents and children from the age 
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of 12 years, and informed assent was given by children aged <12 years. Questionnaires 
were filled out in a subset of children by either parents/caretakers or children >12yr of 
age, covering hair care characteristics, general health and use of medication. Information 
was obtained about washing frequency (<1, 1-2, 3-4, or >4 times per week), use of hair 
product on the day of sampling (yes/no, type of product: none, mousse, gel, wax, spray, 
other), frequent sweating at the scalp (yes/no), hair treatment, e.g. dyeing, bleaching, or 
perming, in the past three months, topical use of GCs and current smoking status (yes/
no). In children who did not fill out a questionnaire, hair treatment was set to ‘no’ for 
children under the age of 10 years and current smoking status was set to ‘no’ under the 
age of 12 years. Ethnicity was grouped as western and non-western, based on parental 
country of birth. Hair color was coded by two researchers independently and consensus 
was reached for samples with different coding. 
Hair collection and preparation
Hair locks were cut from the posterior vertex, as close to the scalp as possible, using 
small surgical scissors. The posterior vertex has the lowest variation in repeated 
measurement(17). The hair locks were taped to a paper form with scalp end marking 
and stored in envelopes at room temperature. The hair locks were cut in 1 cm segments, 
the proximal 3 cm of hair was used for a single analysis, reflecting the past 3 months. 
Subsequently, hair samples were transferred to glass tubes, weighed (mg), and washed 
for 2 minutes in Liquid Chromatography (LC) grade iso-propanol at room temperature, 
and left to dry for at least 48 hours. 
Hair analysis
Steroids were extracted in 1.5 mL LC-grade methanol for 18h at 25oC in the presence 
of deuterated steroids, the extract was cleaned using solid phase extraction and 
steroids were quantified following a LC-MS/MS based method described elsewhere(16) 
using a Waters Xevo TQ-S system (Waters Corporation, Milford, MA, USA). Steroid 
concentrations are reported in pg per mg hair. Steroid measurement was successful 
in 96.5%, 97.2%, 94.4%, 78.6%, 82.1% and 82.1% for cortisol, cortisone, 17-OHP, 
androstenedione, DHEAS and testosterone respectively. 
Statistical analysis
Statistical analysis were performed in R version 3.1.1(19). Age specific reference ranges 
of steroid concentrations was estimated by estimation of the 2.5th and 97.5th percentile 
curves by a semi-parametric model with Box-Cox transformation, available in the 
‘Generalized Additive Models for Location, Scale and Shape’ package (20). Model fit was 
compared using Akaike’s ‘an information criterion’ combined with visual inspection to 
prevent over fitting. Steroid concentrations were transformed to age-adjusted z-scores 
for subsequent analyses. Associations of hair characteristics, topical GC use, smoking, 
gender and ethnicity with steroid concentrations was assessed using linear regression 
models, adjusted for gender and ethnicity. 
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reSuLtS
Steroid profiles in a total of 288 children at the age of  4.3 – 18.8 years were measured 
to establish reference ranges. The general characteristics of participants are shown in 
Table 1. Questionnaires on hair care characteristics, topical GC use and smoking status 
was completed in a subset of 180 children. 
reference ranges
Reference ranges of steroids over age are listed in Table 2. The reference ranges are 
defined as the predicted 2.5th and 97.5th percentiles, shown in Figure 1. DHEAS and 
testosterone z-scores were significantly lower in girls compared to boys (β=-0.57, 
p<0.001 and β=-0.61, p<0.001 resp.), hence the predicted centiles for these steroids were 
table 1. General characteristics
Variable N=288
Age, years 11.6 (4.1)
Sex, girls/boys 139/149 (48/52%)
Ethnicity, non-western/western 41/231 (15.1%)
Height, cm 156.3 [132.5, 169.0]
Weight, kg 44.0 [26.0, 58.1]
Body mass index 17.6 [15.3, 20.1]
Hair color 
Red 1 (0.4%)
Blond 42 (15.4%)
Dark blonde 79 (29.0%)
Brown 136 (50.0%)
Black 14 (5.1%)
Hair dyed yes/no 7/201 (3.4%)
Washing frequency 
<1x/wk 3 (1.7%) 
1-2x/wk 44 (25.0%) 
3-4x/wk 90 (51.1%)
>4x/wk 39 (22.2%)
Excessive sweating  yes/no 20/148 (13.5%)
Use of hair product yes/no 71/109 (39.4%)
Mousse 3 (4.2%)
Hairspray 6 (8.5%)
Wax 17 (23.9%)
Gel 17 (23.9%)
Other 14 (19.7%)
Multiple 14 (19.7%)
Use of topical steroids yes/no 12/213 (5.3%)
Smoking yes/no 11/243 (4.5%)
Data described as mean (standard deviation), median [interquartile range] or number(percentage).
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modelled separately for boys and girls. Cortisol and cortisone shows a slight increase 
over age with a reduction in variance in adolescents. Androstenedione, 17OHP and 
testosterone show a marked increase over age, leveling off at approximately the age of 14 
years. The median testosterone concentrations are significantly higher in boys than in 
girls, especially in adolescent children. Due to a larger variance of testosterone in girls, 
the 97.5th percentile line is higher in girls than in boys. For DHEAS, concentrations 
increase slightly with age in boys, but not in girls. 
effects of determinants on steroid measurement
Table 3 shows the effects of participant and hair related characteristics on steroid 
z-scores. As only one child had red hair and two children washed their hair less than 
once a week, these results were not included in the analysis. All steroids are lower 
in children of western descent than in children of non-western descent, except for 
DHEAS which is lower in children of non-western ethnicity. Smoking and topical 
GC use was not associated with a difference in steroid concentrations. Hair color was 
associated with differences in steroid concentrations. Blond hair was associated with 
lower 17OHP and black hair was associated with higher DHEAS and testosterone. No 
influence of excessive sweating at the scalp and use of hair products was found. Also 
when analyzed per hair product type, no effects on steroids was found (ANCOVA 
adjusted for sex and ethnicity, all p-values > 0.3). Hair dye was associated with a lower 
cortisone and a higher androstenedione. A  washing frequency of once to twice per 
table 2. Age adjusted reference ranges for steroid profiles in scalp hair
Age
Cortisol Cortisone Androstenedione 17OHP DHEAS Boys DHEAS Girls Testosterone boys Testosterone Girls
2,5 50,0 97,5 2,5 50,0 97,5 2,5 50,0 97,5 2,5 50,0 97,5 2,5 50,0 97,5 2,5 50,0 97,5 2,5 50,0 97,5 2,5 50,0 97,5
4 0,11 1,01 15,6 2,2 7,6 52,0 0,08 0,19 0,78 0,04 0,18 0,64 2,97 8,61 32,03 2,72 8,10 30,13 0,03 0,19 2,07 0,02 0,09 1,90
5 0,16 1,31 17,0 2,4 7,9 48,8 0,07 0,18 0,74 0,06 0,21 0,62 3,26 9,86 39,03 2,66 8,36 33,54 0,03 0,15 1,46 0,01 0,07 1,42
6 0,20 1,52 16,8 2,6 8,1 45,5 0,07 0,18 0,75 0,08 0,24 0,61 3,53 11,10 46,95 2,61 8,63 37,47 0,03 0,13 1,12 0,01 0,07 1,29
7 0,25 1,66 15,8 2,8 8,4 43,0 0,09 0,21 0,91 0,11 0,27 0,64 3,76 12,35 55,96 2,54 8,89 42,04 0,03 0,15 1,09 0,02 0,08 1,59
8 0,29 1,78 14,8 3,1 8,9 42,0 0,11 0,29 1,23 0,13 0,31 0,72 3,96 13,60 66,27 2,47 9,15 47,38 0,04 0,18 1,19 0,02 0,12 2,19
9 0,35 1,93 14,1 3,4 9,6 41,7 0,15 0,37 1,61 0,14 0,35 0,82 4,13 14,85 78,14 2,39 9,42 53,68 0,05 0,20 1,23 0,03 0,17 3,02
10 0,39 1,97 12,7 3,7 10,0 40,7 0,18 0,46 2,06 0,15 0,38 0,92 4,27 16,10 91,87 2,31 9,68 61,17 0,05 0,22 1,17 0,04 0,22 3,91
11 0,41 1,91 11,0 4,0 10,4 39,3 0,23 0,59 2,67 0,16 0,41 1,00 4,38 17,35 107,87 2,22 9,95 70,14 0,06 0,24 1,17 0,05 0,27 4,63
12 0,46 1,98 10,2 4,4 11,2 39,5 0,30 0,77 3,53 0,18 0,47 1,10 4,46 18,60 126,63 2,13 10,21 80,99 0,09 0,31 1,40 0,06 0,30 5,10
13 0,58 2,27 10,6 5,1 12,4 41,2 0,38 0,99 4,63 0,22 0,55 1,30 4,52 19,85 148,77 2,04 10,48 94,23 0,13 0,44 1,83 0,07 0,32 5,30
14 0,73 2,66 11,4 5,8 13,6 42,8 0,47 1,23 5,86 0,25 0,66 1,60 4,55 21,09 175,12 1,94 10,74 110,57 0,19 0,59 2,29 0,07 0,33 5,33
15 0,87 2,96 11,6 6,3 14,5 43,2 0,55 1,47 7,10 0,28 0,77 1,92 4,56 22,34 206,69 1,84 11,01 130,97 0,25 0,74 2,66 0,07 0,34 5,34
16 0,94 3,01 10,9 6,6 14,6 41,3 0,63 1,68 8,28 0,29 0,85 2,22 4,54 23,59 244,85 1,74 11,27 156,76 0,30 0,86 2,87 0,08 0,35 5,30
17 0,97 2,91 9,7 6,5 14,1 37,9 0,70 1,87 9,40 0,28 0,91 2,59 4,51 24,84 291,38 1,64 11,54 189,81 0,35 0,94 2,97 0,08 0,34 5,10
18 0,96 2,73 8,5 6,3 13,2 34,0 0,76 2,05 10,5 0,26 0,96 3,04 4,45 26,09 348,65 1,54 11,80 232,80 0,40 1,02 3,02 0,07 0,32 4,69
Predicted 2.5th , 50th and 97.5th percentiles as reference range cutoffs for age, per year. 
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week was associated with lower 17OHP. No other associations were found between hair 
washing frequency and steroid concentrations. 
diSCuSSion
This study is the first to provide reference ranges of LC-MS/MS measured steroid 
concentrations in human scalp hair in healthy children of 4 to 18 years old, for cortisol, 
cortisone, 17-OHP, androstenedione, testosterone and DHEAS. Measuring steroids in 
scalp hair provides long-term cumulative steroid concentrations over one to several 
months, unaffected by circadian rhythm or acute stress. This method can potentially 
be applied to a wide range of endocrinological issues such as diagnosis and follow-
up of children with (cyclic) Cushing’s syndrome or disease, adrenal insufficiency, and 
congenital adrenal hyperplasia. To date, studies on steroid measurement in human hair 
are scarce, especially in children. Vanaelst et al.(21) measured cortisone concentrations 
in hair of 223 elementary school girls, mean age 8.4 yr., associating cortisone levels with 
stress, life events and coping strategies. The median cortisone concentration of 8.6 pg/
mg found by Vanaelst et al. corresponds to the results found in the current study (8.9 
pg/mg at age 8yr.). Another group who measured cortisol in scalp hair from 10 healthy 
prepubertal children and 10 children with asthma, reported measuring a median of 4.3 
pg/mg and 2.0 pg/mg in the two groups, respectively(22). This is slightly higher than the 
median concentration of 1.8 pg cortisol per mg hair in 8-year old children in this study. 
table 2. Age adjusted reference ranges for steroid profiles in scalp hair
Age
Cortisol Cortisone Androstenedione 17OHP DHEAS Boys DHEAS Girls Testosterone boys Testosterone Girls
2,5 50,0 97,5 2,5 50,0 97,5 2,5 50,0 97,5 2,5 50,0 97,5 2,5 50,0 97,5 2,5 50,0 97,5 2,5 50,0 97,5 2,5 50,0 97,5
4 0,11 1,01 15,6 2,2 7,6 52,0 0,08 0,19 0,78 0,04 0,18 0,64 2,97 8,61 32,03 2,72 8,10 30,13 0,03 0,19 2,07 0,02 0,09 1,90
5 0,16 1,31 17,0 2,4 7,9 48,8 0,07 0,18 0,74 0,06 0,21 0,62 3,26 9,86 39,03 2,66 8,36 33,54 0,03 0,15 1,46 0,01 0,07 1,42
6 0,20 1,52 16,8 2,6 8,1 45,5 0,07 0,18 0,75 0,08 0,24 0,61 3,53 11,10 46,95 2,61 8,63 37,47 0,03 0,13 1,12 0,01 0,07 1,29
7 0,25 1,66 15,8 2,8 8,4 43,0 0,09 0,21 0,91 0,11 0,27 0,64 3,76 12,35 55,96 2,54 8,89 42,04 0,03 0,15 1,09 0,02 0,08 1,59
8 0,29 1,78 14,8 3,1 8,9 42,0 0,11 0,29 1,23 0,13 0,31 0,72 3,96 13,60 66,27 2,47 9,15 47,38 0,04 0,18 1,19 0,02 0,12 2,19
9 0,35 1,93 14,1 3,4 9,6 41,7 0,15 0,37 1,61 0,14 0,35 0,82 4,13 14,85 78,14 2,39 9,42 53,68 0,05 0,20 1,23 0,03 0,17 3,02
10 0,39 1,97 12,7 3,7 10,0 40,7 0,18 0,46 2,06 0,15 0,38 0,92 4,27 16,10 91,87 2,31 9,68 61,17 0,05 0,22 1,17 0,04 0,22 3,91
11 0,41 1,91 11,0 4,0 10,4 39,3 0,23 0,59 2,67 0,16 0,41 1,00 4,38 17,35 107,87 2,22 9,95 70,14 0,06 0,24 1,17 0,05 0,27 4,63
12 0,46 1,98 10,2 4,4 11,2 39,5 0,30 0,77 3,53 0,18 0,47 1,10 4,46 18,60 126,63 2,13 10,21 80,99 0,09 0,31 1,40 0,06 0,30 5,10
13 0,58 2,27 10,6 5,1 12,4 41,2 0,38 0,99 4,63 0,22 0,55 1,30 4,52 19,85 148,77 2,04 10,48 94,23 0,13 0,44 1,83 0,07 0,32 5,30
14 0,73 2,66 11,4 5,8 13,6 42,8 0,47 1,23 5,86 0,25 0,66 1,60 4,55 21,09 175,12 1,94 10,74 110,57 0,19 0,59 2,29 0,07 0,33 5,33
15 0,87 2,96 11,6 6,3 14,5 43,2 0,55 1,47 7,10 0,28 0,77 1,92 4,56 22,34 206,69 1,84 11,01 130,97 0,25 0,74 2,66 0,07 0,34 5,34
16 0,94 3,01 10,9 6,6 14,6 41,3 0,63 1,68 8,28 0,29 0,85 2,22 4,54 23,59 244,85 1,74 11,27 156,76 0,30 0,86 2,87 0,08 0,35 5,30
17 0,97 2,91 9,7 6,5 14,1 37,9 0,70 1,87 9,40 0,28 0,91 2,59 4,51 24,84 291,38 1,64 11,54 189,81 0,35 0,94 2,97 0,08 0,34 5,10
18 0,96 2,73 8,5 6,3 13,2 34,0 0,76 2,05 10,5 0,26 0,96 3,04 4,45 26,09 348,65 1,54 11,80 232,80 0,40 1,02 3,02 0,07 0,32 4,69
Predicted 2.5th , 50th and 97.5th percentiles as reference range cutoffs for age, per year. 
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figure 1. Reference ranges steroid concentrations over age. Steroid concentrations plotted against age, 
lines showing predicted 2.5th, 50th and 97.5th percentiles for cortisol, cortisone, androstenedione and 
17-hydroxyprogesterone (17OHP). For DHEAS and testosterone the dotted lines represent ranges in 
girls and solid lines in boys. Circles represent boys, triangles girls. 
The difference may derive from the small sample-size or differences in methods in the 
study by Kamps et al.(22) They reported processing 95-150 mg of hair, whereas we regard 
40 mg as the absolute maximum amount of hair, and prefer to process 10-20 mg of hair, 
to avoid matrix interference.(16) Since 2012 three studies reported on steroids in scalp 
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hair of adults. When compared to children at the age of 16 – 18 years participating in 
the current study, the concentrations reported by Gao et al.(15) for cortisol, cortisone, 
androstenedione and testosterone are all approximately twice the concentration 
measured in the current study. Cortisol and cortisone concentrations measured in two 
Chinese cohorts (mean age 41 and 38 years) by Chen et al.(23) were even higher (median 
concentrations cortisol 15.9 and 5.1pg/mg, cortisone 57.9 and 62.1 pg/mg) whereas 
DHEAS was lower (12.6 and 6.9 pg/mg). The differences in cortisol and DHEAS 
concentrations between the two cohorts are by itself already remarkable. Deshmukh 
et al.(14) reported testosterone concentrations in scalp hair ranging from 0.3 to 11.8 
pg/mg. These differences may in part be explained by differences in the method, for 
example the use of other extraction solvent(14) or a longer extraction period, e.g. of five 
days versus 18 hours.(23) 
Several studies have established steroid reference ranges in children, measured 
in serum. Bailey et al.(24) included 1482 children of 0-18yr and measured a range of 
hormones, amongst which cortisol. Mean cortisol concentrations increased steadily 
from the age of 4 into adolescence, which is in line with the increasing median 
concentrations found in the current study. Kulle et al.(25,26) reported age- and sex-specific 
reference data for serum concentrations of adrenal and sex steroids in children. Total 
serum cortisol and cortisone showed an increase with age after the age of 1 yr, as did 
17OHP. Comparable to the current study, Kulle et al. found no differences in median 
testosterone concentrations between boys and girls up to the age of 12 years, after which 
concentrations increased particularly in boys(26). Androstenedione showed an increase 
approximately initiating around age 9 and increased more significantly around age 12.(25) 
Although the current study embodies hormone concentrations measured in a different 
matrix, the associations with age do show resemblance to hormone studies performed 
in serum. In contrast, DHEAS, of which the concentrations in hair increase linearly 
with age, do not resemble the marked increase in concentrations around adrenarche in 
serum.(27,28) Although we have no explanation for this difference, one could speculate 
that the sulfate form of steroids might less readily diffuse into hair follicle cells, or 
that DHEAS undergoes desulphation upon uptake. Martel et al.(29) showed that several 
enzymes that are able to convert DHEAS into functional steroids are active in skin. 
To our knowledge, this is the first study assessing the effects of potential confounders 
of the measurement of endogenous steroids in human scalp hair using LC-MS/MS. We 
found significant effects of ethnicity and hair color on steroid concentrations. Several 
studies have addressed the effects of potential confounders on cortisol concentrations 
measured in hair using immunoassays. Sauvé et al.(17) found no effects of natural hair 
color on the assay result. Dettenborn et al.(30) compared individuals with different hair 
colors, finding no significant differences in cortisol. Based on the hair colors reported, 
Caucasian participants were probably overrepresented, although no data on ethnicity 
is mentioned. The most striking differences in steroid concentrations associated with 
hair color in the current study are seen in testosterone and DHEAS, which are increased 
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in black hair. This suggests that differences in the makeup of hair represented by the 
color may contribute to the hair steroid content. Furthermore, residual confounding in 
ethnicity may play a role in these findings, as ethnicity was defined in a dichotomous 
variable (western vs. nonwestern), which probably underrepresents the differences 
between ethnicities in the nonwestern group. We found no major effects due to hair 
product use, excessive transpiration at the scalp or washing frequency, which is in line 
with the other studies which assessed these variables in hair cortisol measurement.(11,17,18,30) 
A hair washing frequency of 1-2 times per week was associated with lower concentration 
of androstenedione. Hypothesizing that a higher hair washing frequency may decrease 
hair steroid content, this finding is the opposite of expected, and may well be a type 
1 error. It should be stressed that  associations of steroid concentrations with topical 
glucocorticoid use, smoking and hair treatment are based on small numbers (N=12, 
11 and 7, respectively). Steroid measurement in human scalp hair is a non-invasive 
method, providing insight in long-term steroid concentrations that, when measured in 
other matrices are subject to circadian fluctuations and pulsatile excretion. Strengths of 
this study are its heterogeneous population sample with a wide age range and multiple 
ethnicities. Ethnicity in the Netherlands is strongly associated with immigration, culture, 
different social economic status and education level.(31) It is therefore difficult to identify 
the causal factor in ethnicity affecting steroid levels. One limitation in the current study is 
that ethnicity is defined as a dichotomous variable. Further studies with larger numbers 
making sub-categorization may be needed. To establish reference ranges, using a non-
parametric approach is advised requiring a minimum of 120 observations (32). However, 
when partitioning for covariates such as age and gender, the sample size needed increases, 
especially for continuous variables such as age. As changes of steroid concentrations 
occur gradually over time, the concentrations measured for a certain age are assumed 
to contribute to the estimation of reference values of adjacent age categories. This can 
be applied by the estimation of smooth centile curves, which is a popular approach in 
defining reference ranges for variables in pediatric populations(20,33,34). 
The non-invasiveness and easy storage of samples make this method exceptionally 
suitable for the pediatric clinical practice. Although clinical validation is warranted, 
long-term steroid profiling in scalp hair may provide new insights and novel clinical 
applications in a range of endocrinological diseases, e.g. diagnosis and treatment follow-up 
in Cushing’s syndrome, adrenal insufficiency, congenital adrenal hyperplasia, male hyper- 
and hypogonadism, and female hyperandrogenism. This study provides the background 
knowledge needed for implementation of hair steroid profiling in clinical research. 
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abStraCt 
Context
Pathologically increased cortisol exposure induces obesity but it is not known whether 
relatively high cortisol within the physiological range is related to childhood obesity.
objective
To compare hair cortisol concentrations between obese and normal weight children.
design
An observational case-control study.
participants
Twenty obese children (Body Mass Index-standard deviation score, BMI-SDS>2.3) 
and 20 age- and sex-matched normal weight children (BMI-SDS<1.1) aged 8-12 years 
were recruited.
main outcome measures
Scalp hair samples from the posterior vertex were collected and hair cortisol 
concentrations were measured using ELISA. Body weight, height and waist circumference 
were measured. From the obese children additional data on blood pressure and blood 
lipid concentrations were collected. 
results
In both groups 5 boys and 15 girls were included: their mean age was 10.8±1.3 vs. 
10.8±1.2 years (obese vs. normal weight, n.s.). Body weight, BMI, BMI-SDS and waist 
circumference were higher in the obese compared with the normal weight children 
(69.81±17.17 vs. 35.46±7.23 kg, 29.6±4.9 vs. 16.4±1.6 kg/m2, 3.4±0.5 vs. -0.2±0.8 SDS, 
94±13 vs. 62±6 cm, p<0.001 all). Hair cortisol concentration was higher in obese 
compared with normal weight children (median [IQR]: 25 [17, 32] vs. 17 [13, 21] 
pg/mg, p<0.05).
Conclusions
Hair cortisol concentrations, a measure for chronic cortisol exposure, were higher in 
obese compared with normal weight children. This suggests chronic activation of the 
hypothalamus-pituitary-adrenal axis in obese children and may provide a novel target 
for treatment of obesity in children.
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introduCtion
Childhood obesity is often accompanied by co-morbidities including hypertension, 
impaired glucose tolerance and dyslipidemia. The clustering of these cardiometabolic 
abnormalities is known as the metabolic syndrome(1,2). The symptoms of the metabolic 
syndrome resemble those of Cushing’s syndrome, a disease which is characterized 
by hypercortisolism.  This raises the question whether chronically elevated cortisol 
concentrations in the general population play a role in the development of obesity and 
the metabolic syndrome. 
Several studies have shown a positive association between cortisol levels and 
obesity(3,4), body fat distribution(5), insulin sensitivity(3,6), or the metabolic syndrome(7) 
in children or adolescents. Contrarily, other studies observed an inverse association 
between cortisol measures and adiposity(8,9). Also in adults conflicting results have been 
published: some studies report a positive association between cortisol and obesity and 
the metabolic syndrome(10,11), whereas in a review it was recently concluded that there is 
no strong relationship between cortisol and obesity or the metabolic syndrome(12).
In most studies cortisol concentrations have been measured in saliva, urine 
or serum. However, due to the circadian rhythm, pulsatile secretion and the daily 
variation in the secretion of cortisol, none of these sampling matrices is a good measure 
of chronic cortisol concentrations. A more suitable matrix appears to be scalp hair. 
Unbound cortisol and other lipophilic substances are incorporated in scalp hair, which 
grows with an average rate of one centimeter per month in adults(13). A hair sample 
of one centimeter therefore is thought to represent the individual mean exposure of 
free cortisol of one month. Recently, several studies have shown that hair cortisol is 
a reliable marker of long-term endogenous cortisol concentrations(14,15). For instance, 
hair cortisol has been shown to be increased in patients with hypercortisolism and 
when analyzed retrospectively, hair cortisol concentrations corresponded with clinical 
course in patients treated for hyper- or hypocortisolism(16,17). Also in populations 
with higher chronic stress elevated concentrations of hair cortisol have been shown 
compared with control groups(18-20).
In a cohort of adults, Stalder et al. showed a  positive association between Body 
Mass Index (BMI) and hair cortisol concentration(21). Moreover, in normal weight 
adults hair cortisol concentration was positively correlated with waist circumference 
and waist-hip ratio(16). In two other studies in adults, subjects in the highest quartile 
of hair cortisol concentration had a 2.4 fold increased risk of metabolic syndrome(22) 
and a 2.7 fold increased risk of cardiovascular disease(23). However, it is questionable 
whether cortisol concentrations are disturbed early in the clinical course of obesity, i.e. 
in pre-pubertal children.
In the present study we used scalp hair samples to study long-term cortisol 
concentrations in children. The objective was to study whether obese children have 
higher hair cortisol concentrations than children with a normal body weight. 
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materiaLS and metHodS
Subjects
In this cross-sectional case-control study, 20 obese children (Body Mass Index-standard 
deviation score, BMI-SDS > 2.3) and 20 normal weight children (BMI-SDS <1.1) aged 
between 8 and 12 years were included. Obese children were recruited at the obesity 
outpatient clinic of the department of Pediatrics of 2 hospitals in Rotterdam, the 
Netherlands: the Erasmus MC - Sophia Children’s Hospital and the Sint Franciscus 
Gasthuis. All obese children aged between 8 and 12 years visiting these obesity 
outpatient clinics obtained oral and written information about the study. For each child 
who gave consent to participate in the study, an age- and sex-matched normal weight 
child was included. The age- and sex-matched normal weight children were recruited 
at primary schools or among healthy siblings of children visiting the general outpatient 
clinic of the department of Pediatrics of the Erasmus MC - Sophia Children’s Hospital. 
Exclusion criteria were: chronic disease, use of any type of medication and short scalp 
hair (<2 cm). The study was conducted according to the Declaration of Helsinki and was 
approved by the Medical Ethics Committees of the Erasmus MC and the Sint Franciscus 
Gasthuis. Written informed consent was obtained from the parents or caretakers of all 
participants. Children aged 12 years also signed an informed consent form themselves.
measurements
Anthropometric parameters
Body weight and height were measured and BMI was calculated. BMI-SDS was 
calculated based on data from the Dutch National Growth Study 2010 using Growth 
analyser software. Obesity was defined according to the International Task Force 
Obesity cut-off values for BMI. With respect to Dutch children overweight and 
obesity were defined as a BMI-SDS of more than 1.1 and 2.3, respectively(24). Waist 
circumference was measured using a non-elastic flexible tape measure with the subject 
standing without clothes covering the waist area. 
Other measurements
Ethnicity was represented in 2 categories: Caucasian (2 parents Caucasian) and non-
Caucasian (1 or 2 parents non-Caucasian). 
Within the scope of standard care at the obesity outpatient clinics, a blood 
sample was drawn and blood pressure and heart rate were measured and it was 
checked whether the child had the metabolic syndrome, based on the criteria of the 
International Diabetes Federation(25). Blood pressure was expressed as SDS adjusted 
for height and gender(26). The attending pediatrician decided for each individual patient 
which parameters were to be analyzed in the blood; in any case, concentrations of 
total, highdensity lipoprotein (HDL)- and low-density lipoprotein (LDL)- cholesterol 
as well as triglycerides were measured. Serum total cholesterol and triglycerides were 
determined enzymatically, and LDL-cholesterol and HDL-cholesterol were determined 
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using a homogeneous assay on a Hitachi 917 (Roche Diagnostics). In the normal weight 
children no additional measurements were performed.
Hair cortisol measurements
A lock of approximately 100 hairs was cut from the posterior vertex of the scalp, as close 
to the scalp as possible. The hair samples were taped to a piece of paper and the proximal 
side of the hairs was marked. The hair samples were stored at room temperature in an 
envelope until analysis. The total length of the hair was divided in segments of 1 cm 
and the part closest to the scalp was used for further analysis. A minimum of 10 mg of 
hair was weighed and put into a glass vial. The hair samples were cut into small pieces 
of 1-2 mm in length, and 1 ml of methanol was used to extract cortisol from the hair 
samples. The vial was sealed and incubated overnight for 16h at 52oC while gently 
shaking. After incubation, the methanol was transferred to another vial and evaporated 
under nitrogen. Subsequently, the samples were dissolved in 250 µl phosphate buffered 
saline (pH 8.0) and vortexed for 1 min. Before analysis, the samples were vortexed 
again for 30 s. A commercially available ELISA kit for salivary cortisol (DRG GmbH, 
Marburg, Germany) was used to measure cortisol concentrations. Cross reactivity of 
other steroids with the kit’s antibodies was reported as follows: corticosterone (29.00%), 
cortisone (3.00%), 11-deoxycortisol (<1.00%), 17OH progesterone (<0.50%), other 
hormones (<0.10%). Intra-assay variation was below 5% and the interassay variation 
below 8% as stated by the manufacturer(16).
Statistical analysis
Statistical procedures were performed using SPSS version 20 (IBM SPSS Statistics, 
Chicago, IL, USA). Differences in age, body weight, BMI, BMI-SDS and waist 
circumference between obese children and normal weight children were analyzed with 
one-way ANOVA. Hair cortisol concentrations were not normally distributed and 
were logarithmically transformed and subsequently analyzed with one-way ANOVA. 
Correlations of hair cortisol with BMI-SDS and waist circumference were analyzed 
using Pearson’s correlations. A p-value <0.05 was regarded as statistically significant. 
reSuLtS
Subject characteristics are presented in table 1. In both groups, 5 boys and 15 girls were 
included. The mean age of the obese and normal weight children was 10.8 ± 1.3 years and 
10.8 ± 1.2 years, respectively (n.s.). In the group with obese children, 9 were Caucasian 
and 11 were non-Caucasian whereas in the group with normal weight children 15 
were Caucasian and 5 were non-Caucasian. The body weight, BMI, BMI-SDS and 
waist circumference were significantly higher in the obese children compared with the 
normal weight children (p<0.001 all). 
None of the normal weight children was familiar with chronic diseases, including 
diabetes mellitus type 2. None of the obese children had diabetes mellitus type 
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2, but 3 subjects were diagnosed with the metabolic syndrome. The obese children 
had a  systolic blood pressure of 116 ± 13 mmHg, a diastolic blood pressure of 
62 ± 7 mmHg, a hearth rate of 86 ± 12 beats/minute, a total cholesterol concentration 
of 4.22 ± 0.84 mmol/l, a HDL-cholesterol concentration of 1.20 ± 0.32 mmol/l, a LDL-
cholesterol concentration of 2.53 ± 0.74 mmol/l and a triglycerides concentration of 
1.21 ± 0.66 mmol/l, respectively. The children had no other medical diagnoses.
The cortisol concentration in scalp hair was (median with [interquartile range]) 
25 [17, 32] pg/mg in the obese children and 17 [13, 21] pg/mg in the normal weight 
children (p<0.05, figure 1). 
table 1. Subject characteristics of the obese children and the normal weight children
Obese (n=20) Normal weight (n=20)
Age (yr) 10.8 ± 1.3 10.8 ± 1.2
Sex (m/f) 5/15 5/15
Ethnicity (Caucasian/non-Caucasian) 9/11 15/5
Body weight (kg) 69.81 ± 17.17*** 35.46 ± 7.23
BMI (kg/m2) 29.6 ± 4.9*** 16.4 ± 1.6
BMI-SDS 3.4 ± 0.5*** -0.2 ± 0.8
Waist circumference (cm) 94 ± 13*** 62 ± 6
Data are presented as mean ± st. dev. unless otherwise indicated 
BMI: Body Mass Index, BMI-SDS: Body Mass Index – standard deviation score 
One-way ANOVA: *** p<0.001 between obese and normal weight children
figure 1. Scalp hair cortisol concentrations in obese children and normal weight children (median, 
Q1-Q3, min-max). * p<0.05 One-way ANOVA after logarithmically transformation.
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There was a correlation between log hair cortisol concentration and BMI-SDS 
(r=0.407, p<0.01, figure 2A) and between log hair cortisol concentration and waist 
circumference (r=0.430, p<0.01, figure 2B). 
figure 2. Correlation between BMI-SDS and hair cortisol concentration after logarithmically 
transformation (Pearson’s correlation coefficient r=0.407, p<0.01, A) and correlation between 
waist circumference and hair cortisol concentration after logarithmically transformation (Pearson’s 
correlation coefficient r=0.430, p<0.01, B) in children aged between 8 and 12 years.
There was one outlier with respect to hair cortisol concentration in the group with 
obese children; this was a morbidly obese subject with a BMI-SDS of 4.5 and a waist 
circumference of 130 cm (see figure 2). Repeating analyses without this subject resulted 
in similar results, i.e.  a significant difference in hair cortisol concentration between 
obese and normal weight children (p<0.05) and a correlation between log hair cortisol 
concentration and BMI-SDS (p<0.05). 
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diSCuSSion
This case-control study shows that obese children have higher hair cortisol concentrations 
than children with a normal body weight. Hair cortisol concentrations were positively 
correlated with the BMI-SDS and with the waist circumference. These cortisol 
concentrations are a marker of long-term, i.e. 1 month, systemic cortisol exposure. 
This may indicate chronic activation of the hypothalamus-pituitary-adrenal (HPA) axis 
in obese children, however, more research is needed to unravel the role of cortisol in 
childhood obesity. To our knowledge our study is the first to show increased hair cortisol 
concentrations in obese children compared with normal weight children. In the adult 
population, a relationship between BMI and hair cortisol concentration already has 
been shown(21). Moreover, an increased risk of metabolic syndrome or cardiovascular 
disease with increased hair cortisol concentrations has been observed(22,23). Thus, the 
disturbed cortisol concentrations are present early in the course of obesity.
Cortisol is released after activation of the HPA-axis in response to a stressor, which 
may be of physical or psychological nature. Increased cortisol concentrations have 
several effects throughout the body; increased activity of the HPA-axis is therefore 
associated with a variety of conditions(27-30). Several studies have shown a positive 
association between cortisol concentrations and obesity or the metabolic syndrome in 
adults(10,11) and in children or adolescents(3-7). On the other hand, associations between 
perceived or experienced stress and obesity have been shown(29,30). For instance, 
BMI-SDS was higher in those adolescents with moderate or higher perceived stress 
compared with those with low perceived stress(31). In Hispanic girls aged 8-11 years 
with an increased cortisol awakening response, increased school-related stress was 
associated with increased visceral and subcutaneous adipose tissue(32). It is not known 
whether chronically increased cortisol concentrations are cause or consequence of the 
development of obesity and metabolic syndrome. Due to the cross-sectional nature 
of the present study, again no conclusions about causality can be drawn. However, 
if - in parallel to Cushing’s syndrome - increased cortisol exposure at the tissue level 
is the driving force behind this relation, reducing cortisol concentrations may provide 
a novel target for obesity treatment in children. 
Several limitations and directions for future studies can be mentioned. In the 
present study, 75% of the participants were female. All obese subjects aged between 8 
and 12 years visiting the obesity outpatient clinics of the 2 hospitals were approached 
to participate in the study. Because more girls than boys visited the pediatric obesity 
outpatient clinics, a phenomenon often seen in the obesity outpatient clinics in the 
Netherlands, more girls than boys were approached and subsequently included in 
the study. Whether there are differences in hair cortisol concentrations between boys 
and girls at this age needs further study. However, because we included age- and sex-
matched normal weight subjects as a control group, possible gender differences in hair 
cortisol concentrations do not affect the results of the present study. 
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The distribution of the ethnicity of the children was slightly different between the 
two groups: there were more non-Caucasian children in the obese group than in the 
normal-weight group. The relationship between obesity and hair cortisol concentration 
may be mediated by ethnicity; after ANCOVA with ethnicity as covariate, there was 
a  trend for a difference in hair cortisol concentration between obese and normal-
weight children. It is not known yet whether there are differences in hair cortisol 
concentration between different ethnicities, and this needs further study. Another 
explanation may be that obesity occurs more frequently in non-Caucasian children(33) 
and that the group with obese children therefore contained more children with a non-
Caucasian ethnicity compared with the group with normal-weight children. Future 
studies with larger sample sizes are needed to evaluate the effect of perceived or 
experienced stress, pubertal status, ethnicity, or socioeconomic status on hair cortisol 
and obesity in children.
In the present study the growth rate of human scalp hair of 1 centimeter per month 
in adults was also assumed for children aged between 8 and 12 years(13). However, it is 
not completely clear whether the growth rate of scalp hair indeed is the same in adults 
and children. The linear growth of scalp hair in children is poorly studied and there may 
be differences in growth rate between different ages and between boys and girls(34). If 
the assumed growth rate appears to be incorrect, the timeline of long-term hair cortisol 
assessment in children may be somewhat different from the 1 month as presented in 
the present study. However, if this is the case it would be a minor difference of at most 
a few days. Also in children scalp hair cortisol concentrations are a measure for long-
term cortisol concentrations.  
In conclusion, obese children have higher long-term cortisol concentrations than 
normal weight children. This may provide a novel target for future obesity treatment 
in children.
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abStraCt
background 
Childhood obesity is an important risk factor for premature development of the 
metabolic syndrome (MetS) at adulthood. There is need for understanding of the 
mechanisms underlying the MetS and obesity. Patients with Cushing’s disease suffer 
from similar metabolic complications, leading to the hypothesis that inter-individual 
cortisol variation may contribute to the onset of obesity. Additionally, glucocorticoid 
receptor (GR) gene polymorphisms resulting in differential glucocorticoid (GC) 
sensitivity, have been associated with an adverse metabolic profile.
aim
To study associations of GC levels in scalp hair, as a marker of long-term systemic GC 
concentrations, and genetically determined GC sensitivity with obesity and body-fat 
distribution in children.
methods 
We performed a cross-sectional study of cortisol and cortisone concentrations over 
a 3-month period, measured by LC-MS/MS in hair of 3019 6-year-old children 
participating in the Generation R study. Genotyping of GR-gene polymorphisms was 
performed. 
results
Of all children, 4.3% was obese and 13.4% overweight. Cortisol was significantly 
associated with risk of obesity (OR 9.4 (3.3 – 26.9)) and overweight (OR 1.4 (1.0 – 2.0)). 
Cortisone was associated with risk of obesity (OR 1.9 (1.0 – 3.5)). Cortisol and cortisone 
were significantly positively associated with BMI, fat mass (FM) index, and android/
gynecoid FM ratio. GR polymorphisms were not associated with adiposity parameters. 
Conclusion
Long-term cortisol concentrations are strongly associated with an increased risk 
of childhood obesity and adverse body-fat distribution. Future research may reveal 
whether these are causal relations and may be a target for therapy. 
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introduCtion
Childhood overweight and obesity, an important risk factor for premature development 
of the metabolic syndrome and cardiovascular disease later in life,(1) has tripled in 
prevalence since the 1980s, currently affecting approximately 17% of all US children 
and adolescents, with an even higher prevalence in ethnic minorities.(2)  The observation 
that hypercortisolism (e.g. Cushing’s disease or use of prescribed glucocorticoid (GC) 
medication) results in the development of (central) obesity, lead to the hypothesis that 
inter-individual variation in activity of the hypothalamus-pituitary-adrenal (HPA) axis 
may be implicated in the onset of obesity in the general population. 
Multiple studies have targeted the association between GC concentrations and 
obesity, yielding contrasting results on the association between cortisol concentrations 
and adiposity, either reporting a positive association(3-5) between cortisol and obesity, 
no association(6-9) and negative associations.(10-13) Most of these studies comprised 
relatively small sample sizes and measured cortisol in serum, saliva or urine. Although 
cortisol concentrations can reliably be measured in these matrices, they represent 
cortisol concentrations at a single point in time up to 24 hours when urinary analysis 
is performed. These measurements are highly influenced by the circadian rhythm, 
pulsatile excretion and acute stressors. However, obesity is a chronic phenomenon, 
hence glucocorticoid concentrations need to be chronically increased to contribute 
to the development of overweight and obesity. A relatively recent development 
in the measurement of glucocorticoids provides the option to measure long-term 
glucocorticoid exposure by analyzing cortisol and cortisone concentrations in scalp 
hair, which is thought to be less affected by acute changes in glucocorticoid synthesis.(14) 
As hair grows at approximately 1 cm per month, average glucocorticoid concentrations 
over multiple weeks to months can be measured.(15,16) The measurement of cortisone in 
saliva was shown to reflect serum free cortisol levels.(17) Stalder et al.(18) also measured 
cortisone in scalp hair and showed significant associations with the metabolic syndrome 
in adults. Since the availability of long-term cortisol measurement, several studies have 
reported positive associations between cortisol and adiposity parameters(16,19-23), the 
metabolic syndrome(18) and cardiovascular disease.(24)  However, none of these studies 
investigated body composition in more detail. A different approach to assess the 
association between cortisol exposure and body composition is by using polymorphisms 
in the glucocorticoid receptor (GR) gene, known to affect cortisol sensitivity. For 
example, the combined single nucleotide polymorphisms (SNPs) ER22/23EK reduce 
GC sensitivity,(25) and have been associated with a beneficial body composition in young 
adults.(26) On the other hand, the SNPs N363S and BclI have been shown to increase 
GC sensitivity, and have been associated with an adverse body composition.(27-29) To 
date, studies focused on the association of long-term cortisol exposure with childhood 
obesity are scarce. Recently, our pilot study suggested that hair cortisol levels are higher 
in obese children compared to normal weight children.(22) The relationship with body 
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composition has not yet been studied. Hypothesizing that cortisol already has effects 
on body composition and fat distribution at young age, this study aimed to investigate 
the relationships of long-term glucocorticoid concentrations and polymorphisms in 
the GR gene with obesity and fat distribution in children of the general population. 
metHodS
This study is embedded in the Generation R Study, a population based cohort study 
from fetal life onwards situated in Rotterdam, the Netherlands.(30) This study has 
been approved by the local medical ethics committee and informed consent has been 
obtained from the parents or caretakers. In total 6690 children visited the Generation 
R research center at age 6 yr. As the current study started at a later point in time, 3490 
were asked to participate in hair sample studies, of which 3034 children (86.9%) were 
willing to participate. Participants were excluded in case of systemic glucocorticoid 
use (n=8). Genetic data were available in 4046 of the 6690 children visiting the 
Generation R research center (Flow chart in supplements, supplemental figure S1.). 
Maternal education status was used as a proxy for social economic status. Educational 
status information was collected through questionnaires at the child’s age of six years, 
and subdivided in three categories; low (no or primary school only), mid (secondary 
school, college) and high (bachlor’s degree or higher). 
obesity and fat distribution
At the age of 6 years, height and body weight were measured without shoes and heavy 
clothing. Height was measured using a stadiometer (Holtain Limited, Crosswell, 
Crymych, United Kingdom) with a precision of 0.1 cm. Weight was measured to the 
gram with an electronic scale (SECA 888, Almere, The Netherlands). Body mass index 
(kg/m2) was calculated and cut-off values as developed by the International Obesity 
Task Force for overweight and obesity were used.(31) Fat distribution was assessed by 
dual-energy X-ray absorptiometry (DXA) (iDXA, General Electronics Lunar, 2008, 
Madison, WI, USA), equipped with enCORE software v12.6, using low radiation dose 
(standard 3 µGy). Fat mass index was calculated as total body fat mass divided by 
height squared (kg/m2), the android-gynecoid fat mass ratio was calculated by dividing 
the fat mass in the android region by the fat mass in the gynecoid region. 
Hair glucocorticoid measurement
Hair samples of approximately 100 strands were cut from the posterior vertex using 
small surgical scissors, as close to the scalp as possible.  Hair locks were then taped 
to a piece of paper with the scalp end marked, and stored in an envelope at room 
temperature until further analyses. Parents were requested to fill out a questionnaire for 
their child on hair washing frequency, time since last wash, hair product use, and use 
of glucocorticoids. Cortisol and cortisone were measured as described previously,(32) 
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with the exception that hair samples were minced by hand using small surgical 
scissors, instead of using 1 cm segments. Briefly, the proximal 3 cm of hair samples 
were weighed using an electrical scale and minced. Hair samples were then washed 
in LC-grade isopropanol for 2 minutes at room temperature, and left to dry for at 
least 2 days. Deuterium labeled cortisol and cortisone were added prior to extraction. 
Extraction was performed using LC-grade methanol (MeOH), for 18 hours at 25oC in 
the presence of deuterated steroids. Subsequently, the extract was cleaned using solid 
phase extraction and steroids were quantified on a Xevo TQS LC-MS/MS (Waters 
Chromatography).
glucocorticoid receptor genotyping
The glucocorticoid receptor single nucleotide polymorphisms BclI (rs41423247), 
GR-9β (rs6198), N363S (rs56149945, previously designated rs6195) and ER22/23EK 
(rs6189/rs6190) were genotyped in cord blood, as described previously.(33) Genotyping 
was performed using Taqman allelic discrimination assay (Applied Biosystems, Foster 
City, CA, USA), and Abgene QPCR ROX mix (Abgene, Hamburg, Germany). The 
genotyping reaction was amplified using the GeneAmp PCR system 9600 at 95oC for 15 
min, followed by 40 cycles at 94oC (15 sec.) and 60oC (1 min.). Fluorescence detection 
was performed by the 7900HT Fast Real-Time PCR system (Applied Biosystems, 
Foster City, CA, USA), genotypes were determined using SDS software v2.3 (Applied 
Biosystems, Foster City, CA, USA). Genotyping was successful in 97-99% of the samples, 
with an error rate <1% for all polymorphisms. Haplotypes were inferred using PHASE 
software v2.1 (M. Stephens, Dept. of Statistics, University of Washington, Seattle, 
USA). The constructed haplotypes and their distribution are depicted in supplemental 
figure S2.
Statistical analysis
Statistical analyses were performed using R software v3.1.2.(34) Missing covariates 
(ethnicity 2.9%, topical glucocorticoid use 4.9%, hair washing frequency 4.0%, 
time since last hair wash 4.3%, and hair product use 4.4%) were imputed by 
multivariate imputation by chained equations using the R mice package.(35) Multiple 
logistic regression models were performed for the associations between long-term 
glucocorticoid concentrations and obesity and overweight. Associations between 
glucocorticoid concentrations and body mass index and body fat distribution was 
analyzed using multiple linear regression models. The associations between GR 
polymorphisms and body mass index and body fat distribution were analyzed using 
multiple linear regression models, and were performed in all children in which genetic 
data and data on body mass index and body fat distribution were available at the age of 
six years, N=4046 (See flow-chart, supplemental figure S1.). All models were adjusted 
for age, sex, ethnicity and topical glucocorticoid use, unless stated otherwise. Models 
for android/gynecoid fat mass ratio were additionally adjusted for height. Multiple 
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Linear regression models were also used for analyzing the associations between the 
GR SNPs and body mass index and body fat distribution. These models were adjusted 
for age, sex and ethnicity. To adjust for ethnicity in the genetic linear regression 
models, genome wide association study derived principal components identifying 
ethnicity were used.(36) Covariates were regarded confounders when they were either 
correlated with both independent and dependent variables, or when the effect size of 
the association between the independent and dependent variables changed by more 
than 10% upon inclusion of the covariate in the model. Variables that were assessed 
for confounding were hair washing frequency, time since last hair wash, hair product 
use, and maternal education. Dependent variables which are not normally distributed 
were log-transformed. Cortisol and cortisone concentrations were either divided in 
quintiles, or log-transformed after which outliers as defined using Tukey’s definition of 
outliers (Q1-1.5*IQR and Q3+1.5*IQR) were excluded. 
reSuLtS
obesity, overweight, body mass index and fat distribution
Characteristics of the 2953 children (supplemental figure S1) in whom long-term 
cortisol was measured are listed in Table 1. According to the World Obesity Federation 
criteria, 4.3% of the children were obese and 13.4% were overweight. 
Hair cortisol levels were significantly associated with obesity (OR’s 9.4 (3.3 – 26.9) 
for highest cortisol quintile), and also with overweight (OR’s 1.39 (1.0 – 2.0) for highest 
cortisol quintile).  Cortisone was associated with obesity (OR 1.9 (1.0 – 3.5) for highest 
cortisone quintile), but was not significantly associated with overweight (Figure 1, 
Table 2). Hair  cortisol and cortisone concentrations were both significantly associated 
with BMI and fat mass index (Figure 2, Table 3). Cortisol and cortisone were also 
significantly associated with a relative increase in abdominal fat mass, reflected by 
the android/gynecoid fat mass ratio, which is a hallmark of glucocorticoid-induced 
tissue-effects. These results were not changed by additional adjustment for maternal 
education level. Interaction terms for gender, age and ethnicity were not statically 
significant (p’s>0.10).
glucocorticoid receptor polymorphisms 
In 1753 children, data on both the GR gene SNPs and long-term glucocorticoid 
concentrations were available (Flow chart, supplemental figure S1). The SNPs were 
not associated with long-term glucocorticoid concentrations (supplemental table S2). 
The GR-gene polymorphisms were not associated with overweight/obesity, BMI or 
body fat distribution, as listed in supplemental table S1. Furthermore, we observed 
no significant interactions between long-term glucocorticoid concentrations and GR 
gene polymorphisms on overweight, obesity, BMI and body fat distribution (data 
not shown). 
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table 1. Subject-characteristics
Participant Characteristics N=2953
Age (years) 6.2 (0.6)
Sex
Boys 1421 (48.1%)
Girls 1532 (51.9%)
Ethnicity
European 1871 (63.4%)
Non-European 1082 (36.6%)
Maternal education (high) 1595 (54.0%)
Overweight 396 (13.4%)
Obesity 128 (4.3%)
Hair characteristics
Washing frequency
< once a week 553 (18.7%)
1-2 times a week 1430 (48.5%)
3-4 times a week 739 (25.0%)
>4 times a week 230 (7.8%)
Time since last hair wash
<24h 1035 (35.1%)
24-48h 864 (29.3%)
>48h 1053 (35.6%)
Use of hair product (yes)
None 2121 (71.8%)
Gel 364 (12.3%)
Other 231 (7.8%)
Wax 113 (3.8%)
Foam/mousse 86 (2.9%)
Use of glucocorticoids (yes) 233 (7.9%)
Inhalation 79 (2.8%)
Nasal spray 11 (0.4%)
Cutaneous 126 (4.5%)
anthropometrics
Height (m) 1.20 (0.10)
Weight (kg) 23.3 (4.5)
Body mass index(kg/m2) 16.2 (1.9)
body fat distribution
Fat mass index (kg fm/height2) 3.69 [2.37 – 6.92]
Android/ gynecoid fm ratio 0.24 [0.15 – 0.42]
Hair GC concentrations
Cortisol pg/mg 1.7 [0.4 – 38.3]
Cortisone pg/mg 7.7 [2.7 – 33.5]
Values are means (standard deviation), percentages or median [95% range].  Fm, fat mass; GC, glucocorticoid. 
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figure 1. Association of long-term glucocorticoid concentrations with overweight and obesity. 
Logistic regression models adjusted for age, sex, ethnicity and topical glucocorticoid use. Obesity and 
overweight based on the World Obesity Foundation age and sex specific cut-offs. *p<0.05; **P<0.01; 
***p<0.001. 
diSCuSSion
This study shows surprisingly strong associations of long-term cortisol concentrations 
with obesity and adverse body fat distribution, already at the age of 6 years, which 
is independent of social economic status (as assessed by maternal education status). 
These results underline the previous associations between long-term cortisol measured 
in scalp hair and body composition reported in children,(21,22) and adults(16,18,37). This is 
the first study in which obesity is associated with long-term cortisol concentrations 
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table 2. Association of long-term glucocorticoid concentrations with overweight and obesity 
1 2 3 4 5
Cortisol quintiles
Overweight 10,5% 10,3% 15,8% 15,1% 14,2%
Obese 0,69% 4,12% 3,60% 6,35% 7,02%
+ 11,2% 14,4% 19,4% 21,4% 21,2%
Cortisone quintiles
Overweight 12,7% 11,2% 13,1% 14,0% 16,0%
Obese 2,79% 4,71% 4,01% 4,54% 5,40%
+ 15,5% 15,9% 17,1% 18,5% 21,4%
Percentage of children categorized as overweight or obese based on the World Obesity Foundation age and sex 
specific cut-offs. 
table 3. Associations between long-term glucocorticoid concentrations and body composition/fat 
distribution
Cortisol Cortisone
BMI 0.19 [0.12 – 0.26] 0.10 [0.03 – 0.17]
Fat mass index, SDS 0.05 [0.01 – 0.09] 0.06 [0.02 – 0.10]
Android/Gynecoid fm, SDS 0.04 [0.00 – 0.08] 0.06 [0.02 – 0.10]
Beta’s en 95%CI based on linear regression models adjusted for age, sex, ethnicity and topical glucocorticoid use.
measured in hair by LC-MS/MS, which has superior sensitivity and specificity compared 
to immunoassays. Additionally, this study is the first of its magnitude including 2953 
children whereas a previous studies, e.g. by Veldhorst et al.(22) included 20 obese and 20 
normal weight children and should be regarded as a pilot-study. This study also adds 
the exploration of fat mass indices through measurements by DEXA scans, which aids 
in assessing fat distribution with high precision. 
In literature, the majority of studies assessing the relation between HPA-axis activity 
and body composition, measured cortisol in serum, saliva and urine, and yielded 
conflicting results.(13) Based on these studies, Abraham et al.(13) concluded there was no 
strong relationship between systemic cortisol and obesity or the metabolic syndrome. 
However, cortisol concentrations measured in serum, saliva or urine represent 
concentrations of only a short time-period to a single point in time. Diurnal rhythm, 
pulsatile excretion and acute stress cause fluctuations in the concentration, causing 
these measurements to poorly reflect the long-term glucocorticoid exposure. However, 
the development of obesity and aspects of the metabolic syndrome require a prolonged 
exposure to increased glucocorticoid concentrations and other contributing factors. 
As scalp hair grows with approximately one centimeter per month, measuring cortisol 
and cortisone in the proximal three cm provides average concentrations spanning 
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three months, with a significantly reduced contribution of acute changes in HPA-axis 
activity. Using this technique, cortisol has repeatedly been associated with (abdominal) 
obesity,(22,37) , the metabolic syndrome,(18) and cardiovascular disease,(24) findings which 
are underscored by the current results of cortisol and obesity in children. 
Increased glucocorticoid sensitivity due to single nucleotide polymorphisms in the 
glucocorticoid receptor gene has been shown to be associated with increased BMI and 
body fatness both in adults and elderly,(27,38) as well as in children.(39,40) In the current 
study, we analyzed the associations of SNPs in the GR gene, known to alter cortisol 
sensitivity, in over 4000 children at the age of 6 years. No associations were found 
with BMI or fat mass. It is unlikely that this would be a lack of power, as the sample 
sizes in the previous studies were less than one tenth of the current sample. Barat et 
al.(39) conducted a study in a group of prepubertal obese children aged 6 to 13 years 
(n=46), showing Bcl1 carriers to have a higher fat percentage and to be relatively 
cortisol resistant. Both the selection of obese children and the relative higher age may 
explain the contradiction with the current study. In the study by Voorhoeve et al.(40), 
two cohorts of apparently healthy adolescents in the age of with a mean age of 11.3 and 
12.9 years with a generational difference of 20 years were included. Only in the younger 
(age 11.3yr) and later established cohort, and only in boys an association between 
Bcl1 G-allele carriage and increased body mass index and fat mass was established. 
One explanation for the contradicting results between these studies and the current 
findings may be that the associations between cortisol sensitivity and body fatness may 
be more pronounced in adolescence compared to children at 6 years of age. A different 
study, although very early in life, assessing the association between GR gene SNPs with 
growth characteristics in neonates, did not report a significant effect of differential 
GR gene SNPs.(33,41) Additionally, in the current study no associations with GR gene 
SNPs and long-term glucocorticoid concentrations were found. This is the first study 
to assess the association between scalp-hair glucocorticoids and GR polymorphisms. 
As the GR is involved in cortisol feedback, an altered GR glucocorticoid sensitivity 
would be expected to result in altered cortisol concentrations. This has previously been 
tested by Barat et al.(39) measuring a smaller reduction in cortisol concentrations after 
dexamethasone suppression tests in Bcl1 G-allele carriers. HPA-axis negative feedback 
is however not solely regulated by the glucocorticoid receptor. Indeed, the mineral 
corticoid receptor is expressed in the hypothalamus and is thought to play a role in 
basal cortisol concentrations, whereas the glucocorticoid receptor mainly mediates 
stress reactive feedback of the HPA axis.(42) HPA-axis activity in stress Long-term 
cortisol and cortisone concentrations measured in scalp-hair are speculated to better 
reflect the basal cortisol concentrations rather than the short-term stress-induced 
cortisol peaks. Additionally, an interaction between the MR and the GR in HPA-axis 
stress reactivity was shown in mice, with increased expression of the MR inhibiting 
excess HPA-axis stress reactivity in low GR circumstances.(43) It may be speculated that 
polymorphisms in the MR affects GR polymorphisms phenotypes. This would not be 
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detected using dexamethasone suppression tests as dexamethasone is known to have 
no mineralocorticoid effect.
Although we categorized overweight and obesity based on the commonly used age 
and sex-specific BMI cut-off values reported by the World Obesity Foundation,(31) the 
body fat distribution in school age children may not be adequately represented by the 
body mass index. Indeed, total body fat mass and abdominal fat mass were shown to 
be stronger associated with cardiovascular risk factor compared to, and independent 
from body mass index.(44) Hence, fat mass index and distribution were assessed by low-
dose DEXA scans. The ratio between abdominal fat mass and fat in the hip region 
was used as a proxy for waist-hip circumference, to assess whether glucocorticoids 
were preferably associated with the metabolically adverse abdominal fat accumulation. 
Long-term glucocorticoid concentrations were positively associated with both fat mass 
index and the abdominal to hip fat mass ratio.
The main strengths of this study are the large number of participating children, 
the population-based design, and the prospective data collection in a specialized 
research center. A long-term measurement for glucocorticoids was used, which is less 
affected by acute factors and the circadian rhythmicity compared to other matrices. 
The method for glucocorticoid measurement was LC-MS/MS based. Compared to 
immune-assays, this provides improved sensitivity and lacks the cross-reactivity, and 
hence is the advocated method for steroid quantification.(45) One drawback of this 
study is that its design does not easily allow for establishing causality, due to potential 
residual confounding and reverse causality.
The fact that high glucocorticoid concentrations have adverse metabolic effects is 
best demonstrated in Cushing’s syndrome, which may be induced by both endogenous 
and exogenous glucocorticoid excess. Obesity, hyperglycemia and dyslipidemia are 
hallmark symptoms of Cushing’s syndrome. Obesity is induced by glucocorticoid excess 
through multiple mechanisms. For example, glucocorticoids tend to increase appetite, 
they stimulate adipogenesis through preadipocyte differentiation and hypertrophy 
particularly in central fat, and glucocorticoids negatively affects brown adipose tissue, 
which is thought to decrease energy consumption. These mechanisms and others are 
more extensively described in a comprehensive review by Fardet and Fève.(46)  It seems 
plausible that less marked increases in glucocorticoid exposure has similar effects, 
albeit less florid. Additionally, multiple factors may be inducing a chronic cortisol 
excess, e.g. an altered HPA setting caused by an adverse environment intrauterine or 
in early life (the Barker hypothesis), chronic stress, relative sleep deprivation, chronic 
inflammation, and high glycemic index food consumption. These potential factors 
were not addressed in the current study and may be a focus for future research. 
Concluding, there is a strong association between chronic glucocorticoid exposure 
and obesity in children, already at the age of 6 years. Future research may reveal 
whether this is a causal relationship and whether cortisol may be a future target for 
preventive and therapeutic strategies to combat obesity. 
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N = 3490
Number of children invited to participate in current 
study
N = 81
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abStraCt  
background
Glucocorticoid replacement therapy in patients with adrenal insufficiency needs to be 
tailored to the individual patient based on body composition and clinical signs and 
symptoms as no objective method for assessment of treatment adequacy is available. 
Current treatment regimens are often not satisfactory, which is shown by the adverse 
metabolic profile and doubled mortality rates in treated adrenal insufficiency patients. 
Measurement of cortisol concentrations in hair reflect the long-term systemic cortisol 
exposure and may be of use in refinement of hydrocortisone treatment. 
objective
We aimed to study whether long-term cortisol (hydrocortisone) levels, as measured 
in scalp hair, are similar in children with adrenal insufficiency  and  healthy children. 
Material and methods
We set up a case control study, measuring anthropometric characteristics and hair 
cortisol concentrations (HCC) in 54 hydrocortisone substituted children with adrenal 
insufficiency (AI patients) in the age of 4-18 years and 54 healthy children matched for 
gender and age. 
results
Mean HCC were significantly higher in AI patients compared to healthy controls 
(mean 13.3 vs 8.2 pg/mg, p=0.02). AI patients also had a higher BMI (p<0.001) and 
waist circumference (WC) (p=0.02). HCC was significantly associated with BMI 
(p=0.002) and WC (p=0.002). HCC explained 13% of the difference in BMI and 29% of 
the difference in WC between AI patients and controls.
Conclusion
Hydrocortisone treated AI patients have increased HCC and adverse anthropometric 
characteristics compared to healthy controls. HCC measurement may be of value in 
identifying overtreatment and thereby improve hydrocortisone replacement therapy.
Hair cortisol in cHildren witH adrenal insufficiency
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introduCtion
Chronic adrenal insufficiency (AI) resulting in glucocorticoid deficiency may result from 
either adrenal (mostly autoimmune) destruction, termed Addison’s disease or primary 
adrenal insufficiency (PAI), from the lack of adrenocorticotropic hormone (ACTH) 
due to a central defect (termed secondary adrenal insufficiency or hypopituitarism) or 
a genetic defect affecting steroid synthesis enzymes, as is the case in congenital adrenal 
hyperplasia (CAH)(1,2). In childhood, the preferred glucocorticoid (GC) hormone 
replacement therapy is hydrocortisone (synthetic cortisol), administered orally thrice 
daily(3,4). Replacement dose and timing should be titrated per individual, because 
pharmacokinetics and pharmacodynamics vary, as does the individual cortisol need(1,4). 
Under dosing is associated with impaired health and may lead to potentially fatal 
adrenal crisis. But also chronic overdosing should be prevented, as this is associated 
with diminished glucose tolerance, obesity, dyslipidaemia and reduced bone mineral 
density(5,6). Although cortisol is routinely measured in serum, saliva or urine, its use in 
therapy monitoring is limited since these parameters only reflect cortisol concentration 
at a single point in time. Measuring cortisol day-curves has been suggested as therapy 
monitoring tool. However, this requires hospital admission and is thus expensive, 
time consuming, and it is difficult to interpret and has been shown not to be superior 
to clinical assessment(4,7,8). Hence, individual titration is based primarily on clinical 
parameters. Subtle over and under treatment are difficult to detect clinically on the 
short term as the clinical symptoms are non-specific and slow to develop(7), but may 
have profound health effects in the long run. Attaining the optimal dose is challenging, 
which is especially true in paediatric patients due to developmental changes in body 
composition and metabolism requiring continuous dose adjustments and is further 
complicated by difficulties concerning therapy adherence which are highly prevalent 
in adolescents(9). A new tool for monitoring and improving glucocorticoid replacement 
therapy would be most welcome.
A recently developed method in which the long-term systemic exposure to cortisol 
can be analysed in human hair gives new perspective(10). Scalp hair at the posterior vertex 
displays regular growth at an average rate of one cm per month(11,12), providing a retrospective 
calendar of mean cortisol exposure and hypothalamus pituitary adrenal (HPA) axis activity 
of recent months to years. Hair cortisol measurement can be applied as a diagnostic and 
follow-up tool for Cushing’s syndrome and disease and even cyclic Cushing’s(13). Cortisol 
analysis in hair has been applied in research addressing, amongst others, stress(14-20) and 
glucocorticoid related endocrine diseases(21,22). Moreover, increased hair cortisol within 
physiological ranges is associated with an increased risk of cardiovascular diseases and 
the metabolic syndrome(23,24). Measuring cortisol concentrations in the hair of adrenal 
insufficiency patients may provide a new tool for monitoring hydrocortisone treatment, 
similar to measurement of the percentage of glycated haemoglobin (HbA1c) as a measure 
for long term glucose concentration in diabetes. 
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Our aims were to determine whether hair cortisol concentrations (HCC) can 
be measured in children with chronic adrenal insufficiency who are treated with 
hydrocortisone, and whether HCC in hydrocortisone treated children were comparable 
to healthy children.
materiaLS & metHodS
participant recruitment
Patients with adrenal insufficiency from the outpatient clinic of the department of 
paediatrics of Erasmus MC- Sophia children’s hospital were asked for participation. 
Inclusion criteria were children aged 0-18yr, diagnosed with adrenal insufficiency due 
to Addison’s disease, hypopituitarism (central or secondary adrenal insufficiency, CAI) 
or Congenital Adrenal Hyperplasia (CAH), who were treated with hydrocortisone for 
six months or longer following national guidelines for steroid dosing. Patients with 
confirmed therapy non-compliance were excluded. Patient recruitment was performed 
from May 2011 until August 2013. A total of 56 patients with adrenal insufficiency 
were recruited after informed consent was given. Hair samples were obtained and 
anthropometric characteristics, being weight (kg), height (m) and waist circumference 
(WC, cm), were measured. Patients were asked to fill out a questionnaire about hair-
treatment and dosing regimens. Written informed consent was obtained from the 
parents/guardians and from patients 12 years and older. For comparison, 55 healthy 
children, matched for age and sex, were recruited by elementary schools visits and 
by asking siblings and friends of patients to participate. Exclusion criteria for healthy 
controls were hair <2cm, use of medication potentially influencing the HPA axis, 
chronic disease or significant illness in the past 3 months. This study was approved by 
the local ethical committee. 
Hair sample collection and analysis
Hair samples of about 100 hairs were taken from the posterior vertex of the scalp, as close 
to the scalp as possible, using small surgical scissors. The samples were taped to a piece 
of paper, the scalp end marked, and stored in an envelope at room temperature until 
analysis. For analysis, the three most proximal centimetres were weighed and cut into 
fine pieces of 1-2 mm in length in glass vials. For extraction, 1 mL methanol was added 
and samples were incubated overnight for 16 hours at 52oC, while gently shaking. After 
incubation, the methanol was transferred into a disposable glass tube and evaporated 
at 37oC under a stream of nitrogen. The extract was then reconstituted in 250 microliter 
phosphate buffered saline (pH 8.0) and vortexed for 1 minute. Cortisol concentration 
was then measured using a commercially available immunoassay kit for salivary 
cortisol (DRG Instruments GmbH, Marburg, Germany), according to manufacturer’s 
instruction manual. The inter-assay coefficients of variation (CV) measured on five 
consecutive assays were 7.0% at 4.4ng/mL, 2.3% at 21.3ng/mL and 8.2% at 35.0 ng/
Hair cortisol in cHildren witH adrenal insufficiency
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mL. The intra-assay CV’s were 3.1%, 2.3% and 2.6% respectively. Sauvé et al.(12) showed 
the total variation of repeated sampling, extraction and measurement to be 15.6%. 
Cross-reactivity reported by the manufacturer are as follows: Corticosterone 29.0%, 
Cortisone 3.0%, 11-Deoxycortiol <1.0%, 17-OH Progesterone <0.5%, other natural 
steroids all <0.10%.
Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics 21 (IBM Corp. Armonk, 
New York, USA). The standard deviation scores (SDS) of height, waist circumference 
(WC) and body mass index (BMI) were calculated based on data from the fourth 
Dutch nationwide growth study 1997(25), using Growth Analyser (Growth Analyser 
BV, Rotterdam, The Netherlands). Patients and controls were compared using paired 
samples t-test. HCC was log-transformed to achieve normal distribution and is reported 
as the geometric mean. Differences in HCC and anthropometric characteristics between 
matched case and control pairs were calculated and correlations of difference in HCC 
(∆HCC) with difference in anthropometrics (∆WC SDS, ∆BMI SDS and ∆Height 
SDS) were analysed using Pearson correlation. Patients with CAH were reciprocally 
compared based on the presence of salt-losing and subgroups of AI patients based on 
aetiology were compared to all controls using one-way analysis of variance (ANOVA), 
adjusted for age and sex. Hair cortisol and hydrocortisone dose associations with 
anthropometric characteristics in the total group of study participants were analysed 
using linear regression. In linear regression analyses of Hair cortisol concentrations 
in the total group, the presence of adrenal insufficiency was included to the model as 
independent variable to assess the additive effect of HCC to diagnosis. A p-value<0.05 
was considered statistically significant.
reSuLtS
In total 56 AI patients were included in the study. Two patients were excluded from 
analysis because of an admitted therapy nonadherence, resulting in a final sample of 54 
patients. Ten patients had been diagnosed with Addison’s disease and 31 patients with 
CAH (17 with salt losing form) of whom 30 patients had 21-hydroxylase deficiency, 
and one patient had 11-β-hydroxylase deficiency. Thirteen patients had been diagnosed 
with central adrenal insufficiency (CAI), of which five cases were caused by a pituitary 
tumour (four patients with craniopharyngioma, one with rhabdomyosarcoma). Nine 
patients with CAI had multiple pituitary deficiencies, all receiving thyroid hormone 
and growth hormone replacement, four patients were treated with oestrogens, one 
patient with testosterone and one patient with vasopressin. Characteristics of the 54 
adrenal insufficiency patients and 55 healthy controls, matched for age and sex, are 
shown in Table 1. Characteristics of children with adrenal insufficiency grouped by 
aetiology are summarized in Table 2. 
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AI patients were found to have a significantly lower height SDS (p<0.001) and 
a higher BMI SDS (p<0.001) and waist circumference (WC) SDS (p=0.018) compared 
to healthy controls. Hair cortisol levels in AI patients were significantly higher than 
in healthy controls (p=0.022, Fig. 1). HCC was higher in all aetiology subgroups 
compared to healthy controls, but this difference only reached statistical significance 
in subgroup of patients with salt losing CAH (p=0.003, adjusted for age and gender). 
∆HCC correlated significantly with ∆WC SDS (r=0.40, p=0.013). The correlation 
with ∆BMI SDS did not reach statistical significance (r=0.26, p=0.054) and ∆HCC 
was not correlated with ∆height SDS  (p=0.80). In AI patients, hair cortisol was not 
correlated with daily hydrocortisone dose in mg/m2 (p=0.41). When cases and controls 
were grouped together, HCC showed a significant association with BMI SDS (log 
transformed β=0.74, p=0.002) and WC SDS (log transformed β=0.69, p=0.002), but 
not with height SDS (p=0.98). Adding HCC to the linear regression model decreased 
the partial effect size for AI, showing that 12.7% of the difference in BMI SDS and 
29.2% of the difference in WC SDS between AI patients and controls was explained by 
HCC. Daily hydrocortisone dose was not associated with height or BMI SDS (p=0.47 
table 1. Characteristics and hair cortisol concentrations
Total Adrenal 
Insufficiency (n=54)
Healthy Controls 
(n=54)
Age, years mean (range) 11.6 (4.2-17.5) 11.4 (4.3-18.0)
Male n (%) 25 (46%) 26 (46%)
Height for age (SDS) mean (SD) -0.61 (1.34) 0.27 (0.80) p<0.001
Waist circumference (SDS) mean (SD) 1.22 (0.90) 0.89 (0.90) p=0.018
BMI (SDS) mean (SD) 0.84 (1.25) -0.04 (0.82) p<0.001
Dosage HC (mg/m2/day) mean (SD) 10.9 (2.7)
Hair cortisol (pg/mg) gm [95%CI] 13.3 [10.3 – 17.2] 8.2 [5.9 – 11.3] p=0.022
P-values from paired samples T test. Gm: geometric mean
table 2. Baseline characteristics of AI patients divided by aetiology  
Addison’s disease 
(n=10)
Congenital Adrenal 
Hyperplasia (n=31)
Secondary adrenal 
insufficiency (n=13)
Age, years mean (range) 13.7 (8.3 – 17.5) 10.8 (5.1 – 17.2) 12.0 (4.2-16.7)
Male n (%) 5 (50%) 15 (48%) 5 (39%)
Height SDS mean (SD) -0.83 (0.99) -0.39 (1.37) -0.96 (1.48)
Waist circumference SDS mean (SD) 1.74 (0.56) 1.15 (0.93) 0.98 (0.99)
BMI SDS mean (SD) 0.17 (1.33) 0.88 (1.08) 1.28 (1.44)
Hair cortisol (pg/mg) Gm [95%CI] 11.8 [5.9 – 22.8] 13.4 [9.7 – 18.3] 14.6 [7.1 – 29.1]
Dosage HC (mg/m2/day) mean (SD) 9.8 (1.9) 11.9 (2.9) 9.4 (1.5)
SDS= Standard deviation score, Gm=geometric mean
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and p=0.25 respectively) but did show a significant correlation with WC SDS (r=0.32, 
p=0.05). Patients with salt losing form of CAH had a higher BMI SDS (mean [95%CI] 
1.13 [0.64 – 1.62] vs. 0.49 [-0.15 – 1.12]), WC SDS (mean [95%CI] 1.38 [0.94 – 1.83] 
vs. 0.81 [0.27 – 1.35]) and HC dose (mean[95%CI] 12.6 [ 11.3 – 13.9] vs. 11.0 [9.3 – 
12.6]) compared to non-salt losing patients, although these differences did not reach 
statistical significance when adjusted for age and sex (p=0.12, p=0.12 and p=0.13, 
respectively). HCC was significantly higher in patients with salt losing CAH compared 
to non-salt losing CAH patients (gm[95%CI] 18.2 [12.8 – 25.7] vs 8.1 [5.0 – 12.9], 
p=0.009, adjusted for age and sex). 
diSCuSSion
To our knowledge, this is the first study reporting hair cortisol concentrations in 
children under GC replacement therapy. In patients with adrenal insufficiency at 
the age of 4-18 years receiving GC replacement therapy, hair cortisol concentrations 
were found to be significantly higher than in healthy controls. Additionally, waist 
circumference and BMI SDS were significantly increased in hydrocortisone treated 
patients, which can partially be explained by increased HCC. These finding probably 
figure 1. Hair cortisol concentrations (HCC, pg/mg hair) in healthy controls and children with 
adrenal insufficiency. Black lines show geometric mean. *p=0.022.
Chapter 7
100
figure 2. Hair cortisol concentrations (HCC, pg/mg hair) in healthy controls and children with 
adrenal insufficiency grouped per aetiology. Black lines show geometric mean. **p=0.012, adjusted for 
age and gender. Filled circles indicate patients with salt losing CAH. 
figure 3. Correlation between paired delta in waist circumference (WC) SDS and paired delta in 
log-10 transformed hair cortisol concentration (HCC). Pearson’s correlation r and p-value depicted 
in graph.
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correlated with inadequate chronic serum cortisol levels, which was revealed by high 
HCC. This suggests that adrenal insufficiency patients are on average over-treated 
with hydrocortisone, resulting in the hallmark sequelae of hypercortisolism such as 
increased BMI and central adiposity. All patients in this study are treated according to 
national GC replacement guidelines, still effects of GC overtreatment were observed 
and long-term cortisol exposure, measured as hair cortisol, was significantly higher 
than in healthy controls. This is in line with previous studies showing increased 
serum cortisol concentrations in AI patients after GC ingestion, compared to healthy 
individuals(7,26). HCC in AI patients are partially overlapping with concentrations in 
healthy controls, the extreme values in AI patients are the most informative results 
which may indicate glucocorticoid over replacement. Hydrocortisone overdosing is 
difficult to identify, as treatment adequacy in AI patients is primarily evaluated through 
the administered GC dose and clinical assessment of the symptoms of over- and under 
treatment(4,7). Serum cortisol and urinary free cortisol (UFC) measurements are not 
useful in treatment adjustment(4,7,27). Clinical symptoms indicating overtreatment are, 
amongst others, weight-gain, increased waist circumference, metabolic syndrome, 
sleep disturbances and skin changes such as acne. These are nonspecific symptoms 
which are often slow to develop(4,28). Filipsson et al. demonstrated overdosing of GC, 
defined as an hydrocortisone equivalent dose of at least 20 mg per day, to be related 
to an adverse metabolic profile, including increased BMI and serum triglycerides and 
total cholesterol, in a large cohort of 2424 patients with hypopituitarism, with and 
without GC treatment(5). These observations have been replicated in patients with 
Addison’s disease(29). Moreover, patients with Addison’s disease treated with GCs were 
shown to have a two-fold mortality rate, mainly due to an increase in cardiovascular 
disease, infectious diseases and cancer  and the authors speculated that this was, at least 
in part, attributable to GC overtreatment(30).
Medicinal therapy is  influenced by absorption, distribution, metabolism and 
excretion. These factors vary between individuals, complicating  prediction of the 
treatment effect in general. This is particularly true during childhood and adolescence, 
as absorption and excretion change over age, distribution is influenced by changes in 
body composition and metabolism is affected by changing hepatic enzyme activity 
and clearance(31). This is even further complicated in cortisol pharmacokinetics, which 
undergo marked changes during puberty(32). Hence, the lack of a correlation between 
the hydrocortisone dose and HCC was not surprising. This is also represented by the 
large range of salivary cortisol concentrations after GC ingestion(33). In a study on HCC 
in patients with adrenal insufficiency, Gow et al.(21) did report a correlation between 
HCC and hydrocortisone dose. However, the patients studied by Gow et al. received 
a large range of hydrocortisone doses from 10 to 60 mg per day and were all adults. 
Hydrocortisone dose in these patients was not adjusted for BSA or body weight, which 
may further increase the difference of cortisol exposure between patients.
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Objectively measuring long-term systemic cortisol exposure may improve current 
GC dosing regimens. Our results suggest measurement of hair cortisol concentration 
may be a novel method for identifying patients receiving supraphysiological 
hydrocortisone doses. Measurement of HCC has been shown to be of value in 
diagnosing and follow-up of Cushing’s syndrome and cyclic Cushing’s disease(13). 
Moreover, elevated cortisol exposure within physiological ranges, as identified through 
HCC measurement, has been associated with increased risk for cardiovascular disease 
and the metabolic syndrome(23,24). In adult AI patients on GC replacement therapy, 
Gow et al. reported increased HCC in patients compared to healthy controls similar 
to our results. No difference in HCC was found between 10 patients treated with 
cortisone acetate and patients treated with hydrocortisone, implicating this method 
can be applied in cortisone acetate treated patients as well. 
One of the strengths of the current study is the sample size of hydrocortisone 
treated paediatric patients with adrenal insufficiency, with a large age range from 
4 to 18 years, and the comparison with age and gender matched healthy controls. 
This study has a wide scope of adrenal insufficiency aetiologies. Moreover, as this 
study has an observational and cross-sectional design, no causal relation between 
hydrocortisone overdosing, HCC and anthropometric effect can be demonstrated. 
Longitudinal intervention studies focused on a more homogeneous patient population 
are required for this, and may be a subject for future research. The current study is 
limited to the analysis of anthropometric data as metabolic data on aspects such as 
glucose and lipid metabolism were not routinely available. Application of the described 
method to children under 4 years of age receiving GC treatment has not been studied. 
Previous studies have shown higher HCC and a larger range in healthy children at 
the age of 1 and 3 years(34). For this age-group, a separate study should be conducted. 
Also for use of glucocorticoid treatment with other aims than replacement, e.g. anti-
inflammatory treatment, additional studies are required. In another study on HCC 
in children performed by Karlén et al.(34) comparable ranges in HCC were found in 
children at the age of 8. Due to the non-physiologic administration of GC in adrenal 
insufficiency patients, HCC equal to those of healthy controls may prove unachievable, 
which is especially true for CAH patients, where GC treatment is not only focused on 
replacement, but also on decreasing ACTH secretion and resulting androgen excess. 
This does not decrease the validity of measuring cortisol in hair in GC treated patients, 
but it may require the establishment of reference ranges in well-controlled AI patients. 
One limitation of hair cortisol measurement is that it provides no direct information on 
systemic cortisol peak exposure directly after ingestion, as the maximal resolution of 
cortisol exposure is approximately one month. Additional measurement of for instance 
salivary cortisol day curves after GC ingestion may yield more information on short 
term peak cortisol exposure and nadir concentrations(33). Furthermore, the potential 
influence of GC stress dosing on HCC has not been assessed in the current or previous 
studies, and warrants further research. 
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Measurement of cortisol concentrations in scalp hair provides clinicians with 
a long-term reflection of systemic cortisol exposure. The method is relatively simple, 
easily implemented and non-invasive, making it especially suitable in the paediatric 
clinical practice. Measurement of cortisol concentrations in scalp hair reflecting long-
term systemic cortisol exposure at the tissue level may provide a new method for 
identifying hydrocortisone overtreatment in patients with adrenal insufficiency. This 
may improve current glucocorticoid replacement quality, limiting long-term negative 
health effects of previously unobserved overtreatment. 
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abStraCt 
background
Glucocorticoid replacement therapy in Congenital Adrenal Hyperplasia (CAH) is 
challenging, especially in children, because both over- and under-dosing may have 
profound and long-lasting adverse effects. Clinical follow-up parameters are largely 
non-specific and slow to develop. Steroid concentrations in scalp hair may be a useful 
monitoring tool, as it provides information on both long-term steroid precursor and 
glucocorticoid exposure. 
aim
We aimed to evaluate scalp hair steroid precursor concentrations as a monitoring tool 
for treatment follow-up in children with CAH.
methods
Scalp hair 17-hydroxyprogesterone (17-OHP) and androstenedione concentrations, 
measured by LC-MS/MS, of children with CAH (N=26) are correlated to concentrations 
in serum and saliva, and were compared to scalp hair concentrations in patient-controls 
with adrenal insufficiency (AI) (N=12) and healthy controls (N=293). 
results
Hair cortisol concentrations were higher in children with CAH, compared to 
both healthy controls (p<0.001) and patient-controls (p=0.05), and did not differ 
significantly between patient-controls with AI and healthy controls. Concentrations of 
androstenedione in scalp hair were strongly correlated with concentrations in serum 
(ρ=0.72, p<0.001) and saliva (ρ=0.82,p=0.002). This was also seen for 17-OHP in hair 
with serum (ρ=0.94, p<0.001) and saliva (ρ=0.69,p=0.009). Both hair 17-OHP and 
androstenedione were higher in CAH patients (mean concentration 17-OHP 2.9 pg/mg; 
androstenedione 1.3 pg/mg), when compared to healthy controls (17-OHP 0.44 pg/mg; 
androstenedione 0.65 pg/mg) and when compared to patients with AI (17-OHP 
0.12 pg/mg; androstenedione 0.32 pg/mg). 
Conclusion
This study shows that scalp hair 17-hydroxyprogesterone and androstenedione 
concentrations seem to be a promising parameter for treatment monitoring in patients 
with CAH.
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introduCtion
Congenital adrenal hyperplasia (CAH) can be caused by a number of autosomal 
recessive genetic defects in the cortisol synthesis cascade. In approximately 95% of 
cases, the defect is located in the steroid 21-hydroxylase (P450c21) gene, causing 
a steroid 21-hydroxylase deficiency leading to cortisol deficiency. The subsequent loss 
of negative feedback in the hypothalamus – pituitary – adrenal (HPA) axis results in 
an overproduction of adrenocorticotrophic hormone (ACTH), resulting in adrenal 
hyperplasia and steroid(-precursor) excess.(1) Several forms of CAH are identified, 
based on the clinical presentation. Less than 1-2% residual enzyme activity causes 
the classical salt-wasting form, in which also aldosterone is deficient, whereas below 
approximately 20% residual activity patients develop the ‘simple virilizing’ form 
without salt-wasting. Both forms are characterized by hyperandrogenism, causing 
premature skeletal maturation with epiphyseal closure, precocious puberty, and in 
girls virilization, often causing ambiguous genitalia at birth. Patients with nonclassical 
CAH, who usually have 20-50% enzyme activity left, mostly have sufficient cortisol 
synthesis capacity. Although about 40% of these patients have an suboptimal 
cortisol respone after synacthen, they suffer primarily from androgen excess and its 
consequences.(2) Hydrocortisone is the preferred glucocorticoid (GC) for replacement 
therapy in children.(3) Therapy prevents cortisol deficiency and thus adrenal crises, 
and subsequently reduces androgen excess by providing negative feedback at the 
hypothalamus and pituitary.(2) Attaining the optimal dosing scheme is challenging. 
Therapy generally results in supra-physiologic cortisol concentrations, which may 
partially explain the reduced adult height, increased body mass index, reduced fertility, 
impaired exercise performance, adverse metabolic profile, impaired quality of life, and 
an increased mortality risk present in CAH patients.(4-7)
The central theme in treatment follow-up in children is focused on preventing 
both GC and steroid hormone excess. Overtreatment with GC is primarily evaluated 
through clinical signs of Cushing’s syndrome, e.g. growth retardation, increased weight 
and adverse body fat distribution. Steroid hormone excess is evaluated through clinical 
signs of increased growth velocity, advanced skeletal maturation, and steroid hormone 
specific symptoms such as hirsutism, acne and virilization.(8) As these symptoms are 
often slow to develop, patients may be over- or undertreated for a considerable time 
before these signs are noted. Current international guidelines advise assessment of 
therapy monitoring by measuring steroid hormone precursors in plasma or saliva 
in a consistent manner, aiming at mildly elevated steroid levels as normal levels of 
17-OHP and the other steroids indicate overtreatment(8). Several limitations apply to 
using hormone concentrations in these matrices; They are highly dependent on the 
time of measurement and intake of medication, provide information of short-term 
steroid hormone concentrations only, and may be falsely increased due to e.g. acute 
stress with ACTH increases or blood traces in saliva. A relatively newly used matrix is 
scalp hair, in which concentrations are not time-dependent, sampling is non-invasive, 
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and long-term steroid exposure can be quantified.(9-11) In a previous immunoassay 
based study, we reported scalp hair cortisol concentrations to be increased in CAH 
patients compared to healthy children.(12) The development of liquid chromatography 
tandem mass spectrometry (LC-MS/MS) based methods for scalp hair steroid profiling 
has provided considerable improvements, as this method has superior sensitivity and 
specificity compared to immunoassays, and provides the capability of measuring 
multiple components among which 17-OH-progesterone and androstenedione, in a 
single run.(13,14) Benefiting from these recent technical advances, adrenal precursor 
hormones essential for CAH follow-up can be quantified simultaneously with cortisol.
The aim of this study is to evaluate scalp hair as a matrix for long-term steroid 
precursor hormone profiling as a novel monitoring tool for treatment follow-up in 
pediatric congenital adrenal hyperplasia patients by assessing the correlations between 
concentrations of the adrenal steroid precursor hormones 17-hydroxyprogesterone 
and androstenedione in scalp hair with those in plasma and saliva. Additionally, we 
aimed to compare cortisol and steroid precursor hormones in scalp hair in patients 
with CAH to healthy controls and to patients with adrenal insufficiency (AI) (without 
steroid hormone excess) treated with hydrocortisone, as patient controls. 
metHodS
participants
Patients with congenital adrenal hyperplasia and/or adrenal insufficiency, attending the 
pediatric outpatient clinic of the Sophia children’s hospital (Erasmus MC, Rotterdam, 
The Netherlands) were requested to participate. Healthy children were enrolled through 
primary and secondary school visits in two cities in the Netherlands, Rotterdam and 
Amersfoort. This study was approved by the local medical ethics committee. All parents 
and children above the age of 12 years provided informed consent, children under the 
age of 12 years provided informed assent. Inclusion criterion for all children was an age 
between 0 and 19 years. The inclusion criterion for patients and patient-controls was the 
use of glucocorticoid replacement therapy for adrenal insufficiency, exclusion criteria 
were use of other medications known to alter steroid or glucocorticoid metabolism, e.g. 
anti-epileptic drugs, or hair shorter than 2 cm. Controls were excluded when systemic 
glucocorticoid were used or when hair was shorter than 2 cm at the posterior vertex. 
data collection
Of all participants, anthropometrics were measured as described previously,(12) and 
information on hair characteristics and hair care were obtained, and hair was sampled. 
The standard deviation scores (SDS) of height, weight and body mass index (BMI) were 
calculated based on data from the Dutch nationwide growth study 1997, using Growth 
Analyser (Growth Analyser BV, Rotterdam, The Netherlands). As parental height was 
not available for healthy controls, target-height SDS was not measured. In all patients, 
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information on medication use was obtained. Serum hormone concentrations used in 
the current study were drawn on the day of hair sampling. Routinely measured saliva 
steroid hormone precursor concentrations measured in patients with CAH within 
three months from hair sampling were used in this study, as hair steroid concentrations 
reflect an average concentration of the past three months (see below). Saliva was 
collected through passive drooling on three consecutive days after awakening, prior to 
hydrocortisone intake. The average concentration was calculated and used for analyses. 
Serum samples were collected either before or after the outpatient clinic visit, after 
intake of medication according to the regular thrice daily hydrocortisone schedule, 
following the ESPE clinical practice guidelines.(15) Serum and saliva concentrations 
were measured in CAH patients only.
measurements of cortisol and steroid precursor hormones
Scalp hair locks of approximately 100 hairs were cut from the posterior vertex, as close to 
the scalp as possible, using small surgical scissors. The proximal three cm of hair, reflecting 
the most recent three months, were used for analysis. The proximal three cm of hair was 
cut in segments of 1 cm in a single vial and measured in a single run. The samples were 
then weighed, washed in 2 mL LC-grade iso-propanol, and left to dry for at least two days. 
Subsequently, steroids were extracted in LC-grade methanol, the extract was cleaned using 
solid phase extraction, and steroids were quantified by liquid-chromatography tandem mass 
spectrometry (LC-MS/MS), as described elsewhere.(14) Steroid hormone concentrations 
were divided by the hair sample weight, and expressed as picogram per milligram 
hair (pg/mg). In subject 17-OH-progesterone and androstenedione were measured 
in serum samples with LC-MS/MS. Steroid hormones were measured simultaneously 
with a method using the CHS™ MSMS Steroids Kit (Perkin Elmer, Turku, Finland). The 
Steroids Kit uses a combined solvent extraction and protein precipitation method with 
acetonitrile containing the deuterated internal standards 2H5-androstenedione and 
2H8-17α-hydroxyprogesterone. The internal standards undergo processing identical 
to the analytes. The chromatographic separation was performed on a Waters® Acquity™ 
UPLC HSS T3 1.8 µm column (diameter 1 mm, length 10 cm) and in-line filter frit 0.2 
µm with acetonitrile/MeOH gradient. A  Waters XEVO-TQ-S system (Waters, Milford, 
MA, USA) equipped with an ESI source operating in the electrospray positive mode. 
Multiple reaction monitoring was applied for the detection of the analytes using both 
quantifiers and qualifiers. The corresponding inter-assay coefficients of variation and 
lower limit of quantification (LLOQ) are the following: 17-OH-progesterone 6.1%; LLOQ 
0.10 nmol/L and testosterone <5%; LLOQ: 0.07 nmol/L.  Both 17α-OH-progesterone and 
androstenedione were measured in saliva by commercially available ELISA methods of 
DRG Instruments (GmbH, Marburg, Germany) (17OHP: SLV-3140 kit; Androstenedione: 
SLV-4780 kit). Both 17α-OH-progesterone and androstenedione were measured in saliva 
by commercially available ELISA methods of DRG Instruments (GmbH, Marburg, 
Germany) (17OHP: SLV-3140 kit; Androstenedione: SLV-4780 kit).
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Statistical analysis
All analyses were performed using SPSS Statistics version 21.0.0.1 (IBM, Armonk, NY, 
USA). Adrenal (precursor) hormones do not follow a Gaussian distribution, therefore, 
log10-transformation was applied and the geometric mean was calculated to describe the 
data. General characteristics between patient and control groups were compared using 
one-way analysis of variance (ANOVA) or the Pearson Chi-Square test. Differences in 
adrenal hormone concentrations were assessed using the Mann-Whitney U test. To 
assess the effects of potential confounders, multiple linear regressions were performed 
on the log10-transformed concentrations, adjusted for age, sex, ethnicity and hair 
color. Correlations between steroid hormones in different matrices were assessed using 
the Spearman correlation coefficient. A p-value below 0.05 was considered to indicate 
statistically significant differences.
reSuLtS
In total 27 children with congenital adrenal hyperplasia were included in this study, 
of which 26 children were diagnosed with 21-hydroxylase deficiency. One child had 
11β-hydroxylase insufficiency and thus was excluded from the study. All children 
were treated with hydrocortisone thrice daily, except for one patient who was treated 
with prednisone, in whom no cortisol concentrations in saliva or hair were measured. 
Of the 26 patients with CAH, 16 (61.5%) had a salt-wasting form and were treated 
with fludrocortisone. Scalp hair analyses were additionally performed in 12 patient-
controls with adrenal insufficiency without steroid hormone excess, all treated with 
hydrocortisone. Of these 12 patient-controls, two were diagnosed with primary 
adrenal insufficiency, and 10 with hypopituitarism, in which case they were treated 
for all deficient hormones adhering to the specific guidelines. Table 1 shows the basic 
characteristics of the patients with CAH and AI, and 293 healthy controls. BMI was 
significantly higher in both patient groups than in healthy controls. Children with AI 
were significantly shorter than children with CAH and healthy controls. Adhering to 
the international guidelines, children with CAH received higher hydrocortisone doses 
compared to children with AI (12.9 vs. 8.7 mg/m2 /24h). Hair cortisol concentrations 
were highest in children with CAH, compared to both healthy controls (p<0.001) and 
patients with AI (p=0.05). Cortisol concentrations in hair did not differ significantly 
between patients with AI and healthy controls (p=0.32). 
Correlations between matrices
Serum and saliva hormone concentrations were not measured at every outpatient-
clinic visit, hence these variables were available for only a subset of the CAH patients 
(N=19 for serum, N=13 for 17-OH-progesterone in saliva, N=11 for androstenedione 
in saliva). Figure 1 shows the correlations between steroid precursor hormones 
measured in scalp hair with concentrations measured in serum and saliva during 
Hair steroid Hormones in cHildren witH congenital adrenal Hyperplasia
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routine follow-up in patients with CAH. Concentrations of androstenedione in scalp 
hair were strongly correlated with concentrations in serum (ρ=0.72, p<0.001) and 
saliva (ρ=0.82, p=0.002). Scalp hair 17-OH-progesterone was strongly correlated 
with concentrations of 17-OH-progesterone in serum (ρ=0.94, p<0.001) and saliva 
(ρ=0.69, p=0.009). 
Scalp hair steroid precursor hormones between groups
Concentrations of scalp hair steroid precursor hormones measured in patients with 
AI or CAH and healthy children were compared, as shown in figure 2. Both 17-OHP 
and Adion were significantly higher in patients with CAH (mean (95%CI) 17-OHP 2.9 
pg/mg (1.4 – 6.4); Adion 1.3 pg/mg (0.7 - 2.3)), when compared to healthy controls 
(mean (95%CI) 17-OHP 0.44 pg/mg (0.40 – 0.48); Adion 0.65 pg/mg (0.56 – 0.75)) 
and when compared to patients with AI due to Addison’s disease or hypopituitarism 
(mean (95%CI) 17-OHP 0.12 pg/mg (0.11 – 0.13); Adion 0.32 pg/mg (0.19 - 0.54)). 
These differences remained statistically significant when adjusted for age, sex, ethnicity 
and black hair color. Both 17-OHP and androstenedione concentrations in scalp hair 
were also significantly lower in patient-controls when compared to healthy controls 
(p<0.001 and p=0.03 resp.). 
Within the patients with CAH, 17-OH-progesterone and androstenedione 
concentrations in hair were not different between boys and girls (p=0.40 and 
p=0.93, respectively). In pubertal children with CAH, hair 17-OH-progesterone and 
androstenedione were significantly higher than in pre-pubertal children with CAH 
(mean (95%CI) 17-OHP 8.7 pg/mg (3.3 – 22.7) vs. 1.0 pg/mg (0.38 – 2.62); Adion 2.6 
pg/mg (1.1 – 6.11) vs. 0.73 pg/mg (0.35 – 1.53)). 
table 1. General characteristics
CAH N=26 AI N=12 Controls N=293 P-value
Sex, female 12 (46.2%) 5 (41,7%) 141 (48.1%) 0.89
Age, yr. (range) 10.6 (5 – 17) 10.0 (2 – 18) 11.5 (3 – 19) 0.23
BMI 21.6 (6.9) 19.8 (5.4) 17.9 (3.3)
BMI – SD score 1.10 (1.23) 0.55 (1.65) -0.11 (1.00) <0.001
Height 145.0 (18.0) 132.9 (30.5) 150.7 (22.9)
Height – SD score -0.14 (1.28) -1.34 (1.56) 0.15 (0.95) <0.001
HC dose, mg/m2/24h (range) 12.9 (8.8 – 16.7) 8.7 (7.2 – 10.3) - <0.001
Pubertal 13 (50.0%) 5 (41.7%) 0.63
Non-western ethnicity 6 (23.1%) 2 (18.2%) 42 (14.3%) 0.58
Hair color black 4 (15.4%) 1 (8.3%) 14 (5.1%) 0.13
Hair cortisol, pg/mg 8.5 (3.2) 4.2 (5.3) 2.2 (2.4) <0.001
Data shown as (geometric) mean (SD) or (range). P-values derived through Pearson Chi-Square or one-way 
ANOVA. AI: Adrenal insufficiency; CAH: Congenital adrenal hyperplasia; BMI: Body Mass Index; SD: Standard 
deviation; HC: hydrocortisone.
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figure 1. Correlations between 17-hydroxyprogesterone and androstenedione in scalp hair with 
serum and saliva in CAH patients. Correlations assessed using Spearman’s correlation coefficient, 
Spearman’s Rho and p-value are displayed in the figures. 
diSCuSSion
In the current study, we show 17-hydroxyprogesterone and androstenedione measured 
in scalp hair of children with CAH to be strongly correlated with concentrations 
measured in serum and saliva. The latter two matrices are usually used for treatment 
follow-up.  Scalp hair steroid precursor hormone concentrations were, as anticipated, 
significantly higher in children with CAH compared to both healthy controls and 
children with AI due to Addison’s disease or hypopituitarism. This study is the first to 
apply steroid hormone measurements in scalp hair to patients with adrenal insufficiency, 
with or without steroid hormone excess. We and others have measured scalp hair 
cortisol concentrations in adrenal insufficiency patients on glucocorticoid replacement 
therapy, showing high concentrations in patients compared to healthy controls.(12,16,17) 
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This is in line with the results of the current study, with cortisol concentrations being 
especially increased in patients with CAH, which is concordant with the higher dosing 
hydrocortisone in this group. The current method adds the value of simultaneously 
measuring multiple  adrenal (precursor) hormones which are important monitoring 
parameters in congenital adrenal hyperplasia.(8) 
Treatment monitoring in patients with CAH focuses on replacing cortisol 
and preventing steroid hormone excess on the one hand, and preventing cortisol 
overexposure with Cushingoid symptoms on the other hand. However, preventing 
steroid hormone excess requires supra-physiologic glucocorticoid doses. The clinician 
is therefore tasked with finding the optimal glucocorticoid dose, with reducing 
steroid hormone excess without inducing Cushing’s syndrome. The continuous bodily 
development in pediatric patients, with changes in body size, body composition 
and metabolism, further complicates establishing and maintaining an optimal dose. 
The health status of adult patients with CAH shows that CAH treatment remains 
a challenge, with side-effects often presenting only on the long term with reduced 
height, cardio-metabolic complications, reduced fertility, and impaired subjective 
health status.(5) 
The opportunity of measuring steroid hormones in scalp hair, provides the clinician 
insight in both the long-term cortisol exposure and steroid hormone exposure. 
As the hair sampling method used does not depend on patient compliance as for 
instance saliva and urine sampling do, scalp hair measurement seems to be a valuable 
therapy monitoring tool. From a practical viewpoint, a lock of 100 hairs is a small 
lock of approximately 0.5 cm across, the scalp-area can be sampled repetitively every 
figure 2. Cortisol,17-hydroxyprogesterone and androstenedione concentrations in scalp hair in 
CAH and (patient)control groups.Box-plots showing scalp hair steroid hormone concentrations in 
patients with adrenal insufficiency (AI), congenital adrenal hyperplasia (CAH) and healthy controls. 
Additionally, 17-OH-progesterone and androstenedione were compared in CAH patients before and 
after puberty. P-values calculated using the Mann-Whitney U test.
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3-4 months, hair sampling is not labor-intensive and non-invasive and therefore also 
suited for the pediatric patient population. 
This study is a cross-sectional study comparing steroid hormone concentrations 
in scalp hair with concentrations in other matrices. A strong point in the current 
study is that steroid hormone measurement in scalp hair was highly correlated to both 
serum and saliva concentrations. Additionally, both patient-controls with AI without 
steroid hormone excess and a large group of healthy controls were enrolled to compare 
with patients with CAH. However, also several limitations apply to the current study. 
The cross-sectional design of the study, although clearly showing a strong correlation 
between concentrations in multiple matrices, does not allow for proving that scalp hair 
steroid hormone profiling can be applied to adjust treatment regimens in patients. For 
this, longitudinal measurements would be needed, showing treatment adjustments to 
be reflected in scalp hair analysis. This may however prove challenging, as treatment 
adjustments are often subtle when disease control is good. Conducting research in 
healthy children, especially in their teens, is a challenge in itself, as participation is 
based on and informed consent from their caretakers but also on willingness and 
assent from the children. Puberty staging was included in the physical examination of 
the children, however due to puberty staging it proved difficult to acquire assent from 
healthy participating children. After eliminating this specific part of the examination, 
healthy children were willing to participate. The result is however that in the current 
study, Tanner stages could not be used as a covariate, which is a significant drawback. 
To compensate for this in part, we included a relatively large control-group. Another 
remark is that in this study the most proximal three cm hair was analyzed, reflecting 
concentrations over approximately three months, while concentrations in both serum 
and saliva only reflected the concentrations on a snap-moment within this time span. 
Our study shows that 17-hydroxyprogesterone and androstenedione concentrations 
in scalp hair seem to be a promising parameters for treatment monitoring in patients 
with congenital adrenal hyperplasia. It provides insight into long-term cortisol and 
steroid hormone exposure, and may add to the evaluation of treatment regimens which 
are currently mainly evaluated on the basis of, often nonspecific, clinical evaluations of 
both cortisol and steroid hormone excess.
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Hormone concentrations are measured in varying matrices
Measurement of hormone concentrations is the corner-stone of endocrine practice, 
with determining the concentrations at the target organs being the ultimate goal. 
This is however rarely feasible; thus hormone concentrations are measured in other 
matrices thought to reflect target organ levels. Due to particular hormone and matrix 
characteristics, e.g. molecular structure, lipophilicity, and protein binding, not all 
matrices are suitable for measurement of any hormone. Several commonly used 
matrices for hormone measurement are blood, saliva and urine. Human scalp hair 
analysis is a relatively novel method, applied for measurement of steroid hormones.(1-4)
Serum and plasma are probably the most routinely applied matrix for hormone 
measurement in clinical practice. Several advantages are its relatively easy availability 
through venipuncture, concentrations are often directly interpretable and is less 
dependent on factors such as local metabolism or renal function. However, several 
limitations do apply. For example, hormone concentrations may be dependent on 
binding protein concentrations.(5,6) Serum hormone measurement usually provides 
a concentration on a single point in time, which may be cumbersome to interpret 
for hormones with short half-times and large variances in synthesis, excretion and 
metabolism in time. Moreover, blood sampling can be stress-full for some people, 
which may influence stress-reactive hormone concentrations such as cortisol. 
Saliva sampling may be a good alternative to serum samples. Sampling is non-
invasive, and concentrations are highly correlated to serum sampling, reflecting the 
unbound, free hormone fraction(7). Saliva sampling can be performed at home and 
samples can be send by post mail, which makes it an easy method for establishing 
concentration curves by sampling at several times during a day, without the need for 
hospital admission. Drawbacks are, like blood sampling, the short time-frame for which 
a single measurement interpretable and as such the potential influence of acute stress. 
Additionally, minute blood dilution due to for example eating or tooth brushing may 
result in falsely elevated concentrations, although Granger et al.(8) reported significant 
blood contamination to be rare. Lastly, sampling is dependent on patient compliance, 
which sometimes proves to be less than desired.(9)
Another routinely applied matrix, e.g. in diagnosis of Cushing’s syndrome, 
pheochromocytoma and carcinoid, is urine.(10-12) 24-hour urine sampling provides 
a reliable reflection of hormone synthesis and excretion, and sampling is non-invasive, 
although often proves to be cumbersome. 24-hour urine collection is highly dependent 
on patient compliance, which is directly the largest drawback.(13,14) More-over, renal 
function and total urine volume, as well as short-term stress due to for example inter-
current disease should be taken in to account. Inter-day variation in urine free cortisol 
concentrations may be large, and multiple 24-hour urine portions should be collected 
before CS can be excluded.(14)
Another technique that closely approaches free hormone concentrations at 
the target organ is based on micro-dialysis. Using an automated sampling system 
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of portable size, Bhake et al.(15) create high resolution 24-hour hormone curves 
while subjects reside in their familiar surroundings being able to partake in their 
everyday activities. The micro-dialysis system samples free hormone concentrations 
subcutaneously over adjustable time-periods, separated by air-bubbles between time-
frames. This technique probably best reflects hormone tissue-concentrations through 
a relatively limited invasive method, but requires specialized devices and is limited to 
measurement during single days. 
Human scalp hair as a source for steroid hormone measurement is relatively 
new. In 2000 Cirimele et al.(3) showed a range of glucocorticoids to be measurable in 
human scalp hair, both synthetic exogenous glucocorticoids such as prednisone and 
dexamethasone, but also endogenously synthesized cortisol and cortisone. In more 
recent years, human scalp hair has increasingly been applied for measurement of 
chronic glucocorticoid exposure in a broad variety of clinical research settings.(4,16,17) 
Several advantages apply to hormone measurement in scalp hair. It is non-invasive 
and does not rely on patient compliance, other than assent in donating a small lock 
of hair. The result reflects the retrospective free cortisol fraction and is therefore not 
influenced by binding protein concentrations, which can be elevated due to for example 
oral anticonception. A single hair lock can provide average hormone concentrations of 
recent months to even years, which renders the improved possibility of diagnosis of 
cyclic Cushing’s syndrome.(18) Factors such as hair washing, hair product use or hair 
treatment seems to have none or a limited effect on the result.(19) Hair color does appear 
to effect the result, although the clinical relevance seems small to moderate (chapter 4). 
The minimal resolution of hair analysis is approximately half a month, hence short-
duration nadir or peak concentrations may be diluted and therefore not measured. For 
this, urine, saliva of serum measurement would be more appropriate. Moreover, hair 
processing is relatively more labor-intensive for the laboratory employees compared to 
fluid matrices, as it requires steroid extraction prior to analysis. As hair follicles are part 
of the skin, one of the target organs of a multitude of hormones, scalp hair hormone 
concentrations may better reflect concentrations at the target organs compared to e.g. 
serum or urine concentrations. 
Any matrix used for hormone concentrations measurement provides merely 
a reflection of hormone concentration at the hormone target organs. Additionally, it 
provides no information on tissue sensitivity, which is dependent on multiple factors 
such as genetic receptor polymorphisms and receptor expression, nor on hormone 
metabolism/degradation.(20) Hence interpretation of a single hormone concentration 
measured in either serum, saliva, urine or scalp hair, should be done with care and in 
light of the clinical condition of a patient. 
methodology 
Steroid hormone quantification methods have long been based on immunosorbent 
assays (immunoassays). Generally, these assays are based on mice or rabbit derives 
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hormone specific monoclonal antibodies, coated on to a well. Samples containing the 
hormone of interest are added, which are bound by the antibodies, after which the 
binding saturation is quantified using differing techniques, e.g. through adding enzyme-
linked antibodies, enzyme-linked hormones (competitive) or by adding radioactive 
labeled antibodies. Immunosorbent assays are widely applied in medical diagnostic 
testing, often using automatic sampling robotics. Also for scalp hair cortisol analysis, 
several immunosorbent assays have been developed and applied with promising 
results.(4,16,21,22) Immunosorbent assays do have their limits however. Especially in 
quantification of low concentrations of sex-steroid hormones, immunoassays proved 
insufficient,(23,24) leading to pleads for alternative methods of steroid quantification 
with higher accuracy, sensitivity and specificity. The combined technique of liquid 
chromatography and mass spectrometry, providing the aforementioned requirements, 
is becoming more readily available for clinical applications such as steroid hormone 
quantification. Hormones are separated in time first through liquid chromatography 
which is primarily based on polarity. Subsequently, hormones are selected based on 
molecular mass to charge ratio. The hormones fulfilling the preselected criteria are then 
fragmented through ion-collision, after which hormone specific fragments are selected 
once again (Tandem mass spectrometry) on mass-to-charge ratio and quantified using 
a mass spectrometer. 
Although liquid chromatography tandem mass spectrometry (LC-MS/MS) is 
generally superior to immunoassays in terms of sensitivity and specificity, both 
techniques have advantages and disadvantages,(25-27) some of which have been listed in 
table 9.1. 
Immunosorbent assays generally do not require specialized devices, but machinery 
which is present at every normally equipped medical diagnostics laboratory. The technique 
needs only basic staff-training and hence can be performed by most laboratory personnel. 
New assays can be readily implemented, are usually widely (commercially) available and 
need little to no lab-adjustments. This is in contrast to state-of-the-art LC-MS/MS, which 
requires specialized personnel and machinery which are costly both in acquisition and in 
maintenance. This hampers the wide availability of LC-MS/MS based assays, and hence 
hampers standardization of techniques across multiple centers.(25)
Sensitivity of immunosorbent assays are adequate for a range of serum hormone 
concentrations which are readily measurable. However, despite a range of assays that 
have been developed, the technique proves insufficient for reliable quantification of 
sex-steroid hormone, especially in the lower concentration ranges. As such, the Journal 
of Clinical Endocrinology and Metabolism announced in 2013 that LC-MS/MS was 
the preferred method for steroid hormone measurement, and declared to adopt this 
preference in their manuscript acceptation policy.(23,28)
Monoclonal antibodies are specific for a single epitope. Steroid hormones are 
structurally closely related (see Chapter 1, Figure 2) and thus show large resemblances, 
despite large variances in physiological effects. This causes antibodies used in 
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immunosorbent assays to potentially bind structurally similar steroid hormones, 
a phenomenon termed cross-reactivity. This may cause falsely elevated hormone 
concentrations and thus false-positive test results, as shown by Monaghan et al.(26) 
in patients treated with Metyrapone (a drug inhibiting 11-betahydroxylase, thereby 
preventing the conversion of 11-desoxycortisol to cortisol) measuring falsely elevated 
cortisol concentrations using an immunoassay, but not when samples were analyzed 
by LC-MS/MS. Newly developed immunoassays are tested for cross-reactivity against 
a selection of relevant hormones or hormone metabolites, which is expressed in 
a percentage reflecting contribution in an equal concentration. However, cross-reactivity 
for untested metabolites cannot be ruled out. Neither can relevant contribution of an 
increased concentration of unknown hormone(metabolites) be excluded in positive 
tests as these concentrations are generally not separately quantified. Due to the multiple 
separation/selection steps in LC-MS/MS, a high specificity can be assured. Additionally, 
multiple components can be quantified in a single run, including (inactive) hormone 
metabolites or synthetic alternatives (e.g. synthetic glucocorticoids such as prednisone 
or dexamethasone). Furthermore, interference due to unknown components causing 
false-positive test results can often be discerned during the result interpretation phase. 
Additionally, the option of measuring multiple components in a single run ultimately 
reduces costs per analyte, and is a strong advantage over immunoassays. However, 
not all cross-reactivity may be clinically irrelevant per se, potentially reducing clinical 
sensitivity in rare cases when using methods with higher specificity.
table 1. ELISA vs. LC-MS/MS pros and cons
ELISA LC-MS/MS
+ Low acquisition costs - High acquisition costs
+ Basic lab technology - Specialized machinery
+ basic trained lab-personnel - Specially trained personnel required
- Generally inferior sensitivity + High sensitivity
- Cross reactivity + High specificity, noticeable interference
- Single component + Multiple components in single run
basic determinants of scalp hair steroid hormones 
In chapters two and four, we tested the effects of several potentially confounding factors 
on scalp-hair hormone measurement. Most determinants of scalp hair steroid hormone 
concentrations tested in these studies, such as hair washing frequency, hair product 
use, hair treatment and sweating at the scalp did not consistently or only marginally 
influence hormone concentrations measured. Darker hair color was associated with 
higher concentrations of DHEAS and testosterone. In different study-samples cortisol 
and cortisone concentrations were found to be higher in black hair.(29,30) Hence, hair color 
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should be taken into account in interpretation of scalp hair hormone concentrations. 
The exact mechanism has not yet been revealed, but hair melanin concentrations have 
been suggested to increase the scalp hair binding capacity. Rollins et al.(31) assessed codeine 
concentrations in individuals with hair colors ranging from red to black. They reported 
higher codeine concentrations in scalp hair with higher melanin concentrations, with 
up to 15-fold higher codeine concentrations in black hair.(31) These marked differences 
were not observed in hair cortisol and cortisone concentrations. The largest difference 
we observed in over 2800 children were mean HCC 1.4 pg/mg in blond children and 
2.4 pg/mg in children with black hair. In an adult population, Staufenbiel et al.(30) 
reported a linear regression coefficient of 0.084 for black hair compared to blond hair. 
The differences in hair codeine concentrations due to hair color are vastly larger than HCC 
differences. As such, hair melanin concentrations may not be as relevant in hair steroid 
hormone incorporation. An alternative pathway may be that the higher melanin content 
of dark hair protects from cortisol decline by UV radiation. In a recent study, Wester et 
al.(32) demonstrated hair cortisol concentrations to be reduced after UV radiation and 
after exposure to natural sunlight. Hence sunlight exposure might be another variable 
to be taken into account when assessing hair steroid hormone concentrations. Several 
studies assessed an array of possible confounding determinants of hair steroid hormone 
concentrations(19,29,30). Although several factors have been found to be associated with 
altered concentrations, the differences are rather limited, as may be their relevance. In 
large epidemiological studies, it is important to collect data of possible confounders, 
as these may significantly bias study results. In clinical application of scalp hair steroid 
hormone measurements, these factors are of less importance as the absolute hormone 
concentrations differences that discern health from disease are usually much larger than 
confounder effects. For example, Manenschijn et al.(18) described a 14-fold increase in 
mean HCC in Cushing’s syndrome patients compared to healthy controls. Additionally, 
in chapter 8 we reported a six fold higher 17-OHP concentration in children with 
congenital adrenal hyperplasia compared to healthy children.(33) 
Scalp hair hormone origin
The exact mechanism of cortisol incorporation in the hair shaft has not yet been 
elucidated. Several theories have been postulated, e.g. through passive or active 
diffusion from blood, the sebaceous gland or through sweat at the scalp. All mechanisms 
potentially contribute, although there seems to be a consensus that diffusion from 
blood and surrounding tissues probably has the largest contribution. 
An alternative method of cortisol incorporation in hair is postulated based on 
research by Ito et al.(34) describing the presence of a complete HPA-axis homolog within 
the hair follicle. According to Ito et al. cortisol is produced locally in the hair follicle, thus 
cortisol measured in scalp hair may potentially originate from local synthesis. Human 
hair follicles were cultured in 1*10-7M CRH for a total of four days, after which cortisol 
and its metabolites were quantified using HPLC. It is unclear why the hair follicles 
were incubated for multiple days in the presence of CRH or ACTH, as the systemic 
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HPA-system is a swift-acting negative feedback loop, with cortisol release in a matter of 
minutes after HPA stimulation. Nevertheless, Ito et al. conclude that human hair follicles 
contain a complete HPA axis including steroid synthesis, secretion and negative feedback. 
In what proportion this contributes to systemic cortisol concentrations or the scalp hair 
cortisol content is unclear. The expression of many genes related to steroidogenesis 
and the HPA-axis in hair follicles has been described, but gene expression profiling in 
isolated hair follicles does not confirm this unequivocally.(35) A comprehensive study of 
gene expression in various human tissues, including skin, was published by Dezso et 
al.(36), showing that steroidogenic and HPA-axis related genes are indeed expressed in 
skin, however this expression reaches levels that are three to six orders of magnitude 
lower than those in the adrenal gland. We consider it likely that in hair follicles similar 
observations would be made. For this reason, we think that a serious role for peripheral 
(skin and hair follicles) HPA and steroidogenesis is doubtful. Additionally, in Addison’s 
disease, cortisol synthesis is impaired due to adrenal destruction through an autoimmune 
process, in which auto-antibodies against 21-hydroxylase, an obligatory enzyme in 
cortisol synthesis, often are present and are thought to play a role in pathophysiology.(37) 
For hair follicles to synthesis cortisol, the enzyme 21-hydroxylase ought to be present. 
Nevertheless, alopecia due to autoimmune destruction of hair follicles is not associated 
with Addison’s disease. Neither can cutaneous cortisol synthesis prevent an Addison’s 
crisis, despite increased ACTH levels having a marked effect on skin melanocyte 
stimulation, resulting in the marked skin tanning. Patients suffering from adrenal 
insufficiency generally receive hormone replacement therapy. This is however inadequate 
to suppress pituitary ACTH synthesis, as is evident from androgen excess in patients 
with congenital adrenal hyperplasia.(38) One would expect markedly elevated scalp hair 
cortisol concentrations if high systemic ACTH concentrations would stimulate hair 
follicle cortisol synthesis. However, studies reporting on hair cortisol in patients with 
adrenal insufficiency report cortisol concentrations comparable to healthy controls, with 
slightly increased concentrations which are thought to be the result of hydrocortisone 
overdosing rather than local cortisol synthesis.(39,40) Concluding, the clinical relevance of 
the presence of an HPA-axis homolog within the hair-follicle remains to be established, 
but seems to be limited in the light of current knowledge. 
Long-term glucocorticoids measured in scalp hair is associated  
with obesity
Chapters 5 and 6 describe a clear association between long-term glucocorticoid 
concentrations and body composition.(41) Hair cortisol concentrations in the highest 
quintile is associated with eight-fold increased risk of obesity in six-year old children. 
The studies described in chapters 5 and 6 are cross-sectional observational association 
studies. Hence, no inference on causality of increased endogenous glucocorticoid 
exposure with obesity can be drawn. The potential of glucocorticoids to induce obesity 
is however well known from glucocorticoid therapeutic side-effects, and Cushing’s 
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syndrome, of which obesity is a hallmark symptom.(42) GCs typically increase abdominal 
fat mass causing centripetal obesity, which is in line with the association between 
long-term cortisol concentrations and abdominal fat mass described in chapter 6. 
The combination of this prerequisite knowledge with the findings of an association 
of increased long-term endogenous cortisol concentrations with obesity, renders 
intervention-studies to confirm the obesogenic properties of cortisol obsolete. Further 
research into the causality and directionality of the associations is however warranted. 
One approach to further investigate the GC-obesity association’s direction is 
through applying longitudinal research, measuring long-term cortisol concentrations 
and body-composition development over time. The Generation R study, a population-
based cohort study from fetal life onwards,(43) would be an ideal platform to implement 
this study, as body-composition is measured throughout childhood, along with 
a score of potential determinants of mediators of cortisol concentrations and body 
composition. One of the important advantages of these observational studies in 
children is that the development of body composition can be tracked, as obesity often 
finds its origin in childhood, and contributing factors of the onset of obesity may be 
identified. Base-line cortisol concentrations have been established at the age of six,(29) 
additional measurements at later ages would expand analytical possibilities and clarify 
the direction and relevance of the described associations. Additionally, determinants 
of increased cortisol exposure may be identified. 
Ultimate confirmation of the relation between cortisol and adverse body composition 
could be reached through intervention studies directed at reducing cortisol in obese 
individuals. Several interventions may apply, probably in combination with a patient 
oriented, individualized approach. Interventions may have a social focus, e.g. reducing 
environmental stressors, may focus at psychological or physical determinants such as 
cognitive behavior therapy, sleeping behavior, and eating behavior, or may directly 
influence cortisol exposure through e.g. pharmacological interventions targeted at the 
cortisol-cortisone shuttle enzymes. However, prior to initiation of intervention studies, 
additional observational research on determinants of increased endogenous cortisol 
exposure is important to properly focus future research on obesity reduction. 
Clinical applications of hair steroid hormone analysis
Glucocorticoid and other steroid hormone analysis in scalp hair may benefit endocrine 
practice in diagnosis and treatment follow-up of several clinical issues. Scalp hairs 
properties of slow and steady growth with continuous logging of mean hormone 
concentrations at the tissue level offers a reliable long-term retrospective overview 
of hormone exposure.(20) As reported by Manenschijn et al. this offers the unique 
possibility to diagnose cyclic Cushing’s syndrome months after the active symptomatic 
period, but may also aid in diagnosis of Cushing’s syndrome or Cushing’s disease.(16,18)
In Chapter 7 we have shown cortisol concentrations to be elevated in children with 
adrenal insufficiency compared to healthy controls, which may in part be attributed 
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to hydrocortisone over-exposure.(40) Additionally, in chapter 8, we describe scalp hair 
steroid precursor hormones 17-OH-progesterone and androstenedione to be markedly 
elevated in children with congenital adrenal hyperplasia.(33) These data suggest that 
scalp hair analysis may be of value in treatment follow-up of patients with congenital 
adrenal hyperplasia and perhaps adrenal insufficiency in general. Current treatment 
follow-up, based on clinical assessment of cortisol over- or under dosing markers and 
serum or saliva androgen precursor hormone concentrations.(44) Treatment adjustment 
based on these markers remains a clinical challenge, as clinical symptoms are often 
slow to develop. Serum and saliva concentrations reflect HPA-axis activity at a single 
point in time only and is dependent on acute stress, time of medication intake and 
time of day, hampering interpretation for medication adjustments. Scalp hair sampling 
is independent of timing on the day or with regard to medication intake, and enables 
measurement of a long term mean cortisol exposure and androgen steroid precursor 
synthesis (i.e. HPA-axis activity), providing the clinician with an additional aid in 
adjusting treatment regimens. 
Although the increased scalp hair 17-OHP and androstenedione content in children 
with CAH and the strong correlation with serum a saliva concentrations are promising, 
the current study (Chapter 8) does not correlate hair androgen precursor content with 
clinical end-points.(33) This is however the primary endpoint in clinical practice. Potential 
focus for future studies could be the association of androgen precursor hormones in 
scalp hair and its correlation with clinical endpoints and disease control markers such 
as growth rate and body composition. However, longitudinal observational studies 
on the association of scalp hair steroids with clinical outcomes could be challenging 
as the common dose-adjustments in developing children are often small and happen 
in children with continuous growth and changes in body compensations. These dose 
changes are perhaps too small to detect significant associated changes in scalp hair 
hormone concentrations unless studies are performed for considerably long durations 
in large numbers of children, which would be costly and troubled by the relative rarity of 
CAH. Nevertheless, these studies would be optimal to ensure reliable implementation 
of scalp hair analysis on adrenal precursor hormones in clinical treatment monitoring. 
Measurement of scalp hair steroid hormones is a non-invasive approach which 
is unique in providing a reflection of long-term steroid hormone concentrations. 
Although several determinants of scalp hair steroid concentrations should be taken 
into account, especially when performing large-scale epidemiological studies, the 
clinical relevance of these determinants seems limited. Measurement of scalp hair 
steroid hormones can be of value in multiple endocrine challenges, as appears to be in 
optimizing treatment of children with congenital adrenal hyperplasia. Also in clinical 
research scalp hair analysis proves to be a valuable technique, benefitting from the 
non-invasive sampling, easy storage and measurement of multiple steroid hormones in 
a single run. Additional research is warranted and bound to be performed as scalp hair 
analysis is applied more and more. 
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Summary
The adrenal glands produce a series of steroid hormones which are important in a large 
variety of physiological processes and altered hormone concentrations at the target-
organ level often results in disease. Measurement of hormone concentrations at the 
target organs is however complicated, which is why concentrations are measured in 
surrogate matrices, e.g. serum, saliva and urine. A novel method applies scalp hair 
as a matrix for long-term glucocorticoid hormone measurement. In the first part of 
this thesis, reference ranges of steroid hormones in scalp hair of healthy children are 
established and determinants of scalp hair steroid hormone concentrations are assessed. 
As introduced in chapter 1, the glucocorticoid hormone cortisol is produced by the 
adrenals in a circadian rhythm and production is elevated in stress. Cortisol synthesis is 
under control of the hypothalamus-pituitary-adrenal axis in a negative feedback loop. 
Increased exposure to glucocorticoids results in the Cushing’s syndrome, which shows 
an overlap in symptoms with the metabolic syndrome. Alternatively, a deficiency in 
the ability to synthesis cortisol, or adrenal insufficiency, results in a syndrome which 
is potentially life-threatening without treatment. A subtype of adrenal insufficiency, 
caused by a genetic defect in one of the cortisol synthesis enzymes, causes congenital 
adrenal hyperplasia, a syndrome marked by adrenal insufficiency combined with 
androgen excess. The second part of this thesis is aimed as assessing the relation of 
endogenous long-term cortisol exposure to obesity in children. Additionally, the value 
of scalp hair steroid hormone concentrations in children with congenital adrenal 
hyperplasia is evaluated. 
part i
In chapter 2, we established reference ranges for scalp hair cortisol, measured with 
an enzyme linked immunosorbent assay, in healthy children aged 4 through 14 years 
old. Hair cortisol concentrations (HCC) increase slightly with age up to 10 years, after 
which concentrations reach a plateau. HCC were not associated with gender, puberty, 
nor with hair care characteristics such as hair washing frequency or hair product use. 
In chapter 3, a liquid-chromatography tandem mass-spectrometry (LC-MS/MS) 
based method for simultaneous quantification of six steroid (precursor) hormones 
(cortisol, cortisone, 17-hydroxyprogesterone, androstenedione, dehydroepiandrosterone-
sulphate, and testosterone) in scalp hair is presented. 
Chapter 4 describes the reference ranges of scalp hair steroid (precursor) hormones 
in healthy children aged 4 through 18 years old, measured by LC-MS/MS. Hair washing 
frequency and hair product use did not affect hair steroid hormone concentrations, 
whereas non-western ethnicity was associated with an increase in hair steroid hormone 
content and black hair color was associated with an increased concentration of DHEAS 
and testosterone. 
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part ii
In chapter 5, we compared hair cortisol concentrations in obese children with age- 
and sex-matched healthy controls. Cortisol concentrations were significantly increased 
in obese children compared to normal weight children, suggesting increased chronic 
HPA-activity in obesity. 
In chapter 6, we found hair cortisol concentrations in a population-based cohort 
of 6-year old children to be directly associated with increased body mass index and 
increased total and abdominal fat mass. Increased cortisol was strongly associated with 
an 8-fold increased risk of obesity. Genetic single nucleotide polymorphisms in the 
glucocorticoid receptor gene, affecting cortisol sensitivity, were not associated with 
cortisol concentrations nor with body composition. 
In chapter 7, we compared hair cortisol concentrations measured by ELISA in 
children with adrenal insufficiency (AI) treated with hydrocortisone, to healthy 
controls. We found an increased mean cortisol concentration in AI patients compared 
with controls, and highest concentrations in the group of patients with congenital 
adrenal hyperplasia. This is in line with increased hydrocortisone dosing in patients 
with congenital adrenal hyperplasia to suppress androgen excess. Concluding, hair 
cortisol may be useful in identifying hydrocortisone overdosing in patients with 
adrenal insufficiency. 
Chapter 8 describes cortisol, 17-hydroxyprogesterone and androstenedione 
concentrations measured with LC-MS/MS in scalp hair of children with congenital 
adrenal hyperplasia, adrenal insufficiency without androgen excess, and healthy 
children. As expected, 17-hydroxyprogesterone and androstenedione were markedly 
increased in children with congenital adrenal hyperplasia compared to the control 
groups. Additionally, androgen precursor hormone concentrations in scalp hair 
showed a good correlation with serum and saliva androgen precursor hormones. This 
indicates that scalp hair steroid profiling may prove a useful and non-invasive method 
for treatment monitoring in patients with congenital adrenal hyperplasia. 
Chapter 9 contains a general discussion in which the research described in this 
thesis is reviewed in a broader perspective, and suggestions for future research are 
proposed. 
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SamenVatting
De bijnieren maken meerdere steroïde hormonen welke van belang zijn voor een 
breed scala aan fysiologische processen in het lichaam. Een veranderde hormoon 
concentratie op het niveau van het doelorgaan kan resulteren in ziekte. Het meten van 
de hormoon concentratie op het niveau van de doelorganen is gecompliceerd en vaak 
niet mogelijk. In plaats daarvan worden concentraties gemeten in andere matrices, 
zoals bloed, speeksel en urine. Een recente methode maakt gebruik van hoofdhaar voor 
de bepaling van lange termijn concentraties van glucocorticoïd hormonen (cortisol). 
Het eerste deel van dit proefschrift beschrijft de bepaling steroïde hormonen in het 
hoofdhaar van gezonde kinderen, het vaststellen van normaalwaarden en het evalueren 
van determinanten van hoofhaar hormoon concentraties. 
De introductie, hoofdstuk 1, beschrijft dat het glucocorticoïd hormoon cortisol 
wordt gesynthetiseerd in de bijnieren in een circadiaans (dag-nacht) ritme, welke onder 
andere wordt beïnvloed door stress. Cortisol synthese staat onder controle van de 
hypothalamus-hypofyse-bijnier as (HPA-as) door middel van negatieve terugkoppeling. 
Verhoogde blootstelling aan cortisol of andere glucocorticoïd hormonen leidt tot het 
syndroom van Cushing, waarvan de symptomen overlappen met de symptomen van 
het metabool syndroom. Aan de andere hand leidt een tekort aan cortisol, bijnier 
insufficiëntie (AI), tot een syndroom welke mogelijk levensbedreigend is zonder 
adequate behandeling. Een subtype van AI wordt veroorzaakt door een genetische 
mutatie in een van de enzymen die nodig zijn voor het synthetiseren van cortisol, wat 
leidt tot het adrenogenitaal syndroom, een syndroom gekarakteriseerd door bijnier 
insufficiëntie en een overproductie van androgene steroïde hormonen. Het tweede deel 
van dit proefschrift is gericht op het analyseren van de relatie tussen endogene cortisol 
blootstelling en obesitas in kinderen. Tevens wordt het bepalen van hoofdhaar steroïde 
hormonen concentraties in kinderen met adrenogenitaal syndroom geëvalueerd. 
deel i
In hoofdstuk 2 hebben we normaalwaarden bepaald van hoofdhaar cortisol 
concentraties (HCC), gemeten met een enzyme linked immunosorbent assay (ELISA), 
in gezonde kinderen tussen de 4 en 14 jaar oud. Cortisol concentraties nemen langzaam 
toe met de leeftijd tot 10 jaar, waarna concentraties een plateau bereiken. HCC was niet 
geassocieerd met geslacht, puberteit, noch met hoofdhaar verzorgingsaspecten zoals 
de frequentie van haar wassen of het gebruik van haarproducten. 
Hoofdstuk 3 beschrijft een liquid chromatography tandem mass spectrometry 
(LC-MS/MS) methode voor het simultaan kwantificeren van zes steroïde hormonen 
(cortisol, cortisone, 17-hydroxyprogesterone, androstenedione, dehydroepiandrosterone-
sulphate, and testosterone) in hoofdhaar. 
In hoofdstuk 4 beschrijven we de normaalwaarden voor hoofdhaar steroïde 
(precursor) hormonen gemeten in gezonde kinderen tussen de 4 en 18 jaar oud, 
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gemeten met LC-MS/MS. Hoofdhaar steroïde hormoon concentraties werden niet 
beïnvloed door de haarwasfrequentie of het gebruik van haarproducten. Niet-westerse 
afkomst was wel geassocieerd met een verhoogde concentratie van de meeste hormoon 
concentraties, en zwart haar was geassocieerd met een verhoogde concentratie DHEAS 
en testosteron. 
deel ii
In hoofdstuk 5 zijn de hoofdhaar cortisol concentraties van kinderen met obesitas 
vergeleken met de concentraties kinderen met een normaal gewicht. Dit suggereert een 
chronische verhoogde activiteit van de HPA-as in obesitas. 
In hoofdstuk 6 hebben we gevonden dat in een populatie gebaseerd cohort van 
6-jaar oude kinderen HCC positief geassocieerd is met een hogere body mass index 
en een hoger totale en abdominale vetmassa. Hogere HCC was geassocieerd met een 
8-voudige verhoging van het risico op obesitas. Genetische polymorfisme in het gen 
voor de glucocorticoïd receptor, welke de cortisol gevoeligheid beïnvloeden, waren 
niet geassocieerd met HCC noch met de lichaamssamenstelling bij kinderen op de 
leeftijd van 6 jaar.
In hoofdstuk 7 is de HCC gemeten met ELISA vergeleken tussen kinderen 
met bijnierinsufficiëntie met hydrocortison behandeling en gezonde kinderen. De 
gemiddelde HCC in kinderen met bijnierinsufficiëntie was hoger vergeleken met 
gezonde controles, en de groep met adrenogenitaal syndroom had gemiddeld de 
hoogste HCC. Dit komt overeen met de hogere dosering hydrocortison gebruikt ter 
behandeling van kinderen met adrenogenitaal syndroom om de androgene steroïde 
hormoonproductie te onderdrukken. Concluderend is HCC wellicht waardevol in het 
opsporen van hydrocortison overdosering bij kinderen met bijnierinsufficiëntie. 
Voor hoofdstuk 8 hebben we cortisol, 17-hydroxyprogesteron (17-OHP) en 
androstenedione concentraties gemeten met LC-MS/MS in hoofdhaar van kinderen 
met adrenogenitaal syndroom, kinderen met bijnierinsufficiëntie zonder androgeen 
hormoon overproductie, en gezonde kinderen gemeten. In lijn met de verwachtingen 
waren 17-OHP en androstenedione sterk verhoogd in kinderen met adrenogenitaal 
syndroom vergeleken met de controle groepen. Daarnaast tonen de 17-OHP en 
androstenedione concentraties gemeten in hoofdhaar een goede correlatie met 
concentraties gemeten in serum en speeksel. Dit geeft aan dat het meten van steroïde 
hormoon-profielen in hoofdhaar waarschijnlijk een bruikbare methode is voor het 
vervolgen van de behandeling van kinderen met adrenogenitaal syndroom. 
Hoofdstuk 9 betreft een algemene discussie waarin het onderzoek beschreven in 
dit proefschrift bediscussieerd wordt in een breder perspectief een waarin suggesties 
voor vervolgonderzoek worden gedaan. 
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